Document_and_Entity_Informatio
Document and Entity Information (USD $) | 12 Months Ended | ||
In Millions, except Share data, unless otherwise specified | Dec. 31, 2013 | Feb. 20, 2014 | Jun. 29, 2013 |
Document and Entity Information [Abstract] | ' | ' | ' |
Entity Registrant Name | 'ANADIGICS INC | ' | ' |
Entity Central Index Key | '0000940332 | ' | ' |
Current Fiscal Year End Date | '--12-31 | ' | ' |
Entity Well-known Seasoned Issuer | 'No | ' | ' |
Entity Voluntary Filers | 'No | ' | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Entity Filer Category | 'Accelerated Filer | ' | ' |
Entity Public Float | ' | ' | $179 |
Entity Common Stock, Shares Outstanding | ' | 84,689,234 | ' |
Document Fiscal Year Focus | '2013 | ' | ' |
Document Fiscal Period Focus | 'FY | ' | ' |
Document Type | '10-K | ' | ' |
Amendment Flag | 'false | ' | ' |
Document Period End Date | 31-Dec-13 | ' | ' |
CONSOLIDATED_STATEMENTS_OF_OPE
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 12 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] | ' | ' | ' |
Net sales | $134,242 | $112,643 | $152,827 |
Cost of sales | 125,922 | 113,869 | 121,724 |
Gross profit (loss) | 8,320 | -1,226 | 31,103 |
Research and development expenses | 38,585 | 43,892 | 45,037 |
Selling and administrative expense | 23,813 | 24,289 | 35,138 |
Restructuring charges | 1,915 | 2,338 | 1,047 |
Operating expenses | 64,313 | 70,519 | 81,222 |
Operating loss | -55,993 | -71,745 | -50,119 |
Interest income | 237 | 528 | 576 |
Interest expense | -82 | 0 | -25 |
Other income, net | 1,859 | 1,364 | 245 |
Net loss | ($53,979) | ($69,853) | ($49,323) |
Basic and diluted loss per share (in dollars per share) | ($0.67) | ($0.99) | ($0.73) |
Weighted average basic and diluted common shares outstanding used in computing loss per share (in shares) | 80,991 | 70,721 | 67,771 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $) | 12 Months Ended | ||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | ||
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract] | ' | ' | ' | ||
Net loss | ($53,979) | ($69,853) | ($49,323) | ||
Other comprehensive (loss) income: | ' | ' | ' | ||
Unrealized gain (loss) on marketable securities | 1,371 | 2,193 | -143 | ||
Foreign currency translation adjustment | 3 | 6 | 0 | ||
Reclassification adjustment: | ' | ' | ' | ||
Net recognized gain on marketable securities previously included in other comprehensive (loss) income | -1,779 | [1] | -1,393 | [1] | -193 |
Comprehensive loss | ($54,384) | ($69,047) | ($49,659) | ||
[1] | Amounts reclassified are recorded within Other income, net in the Consolidated Statements of Operations |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash and cash equivalents | $20,947 | $24,949 |
Short-term marketable securities | 3,447 | 17,750 |
Accounts receivable, net of allowance for doubtful accounts of $172 at December 31, 2013 and December 31, 2012 | 15,156 | 12,233 |
Inventories | 21,114 | 18,840 |
Prepaid expenses and other current assets | 3,628 | 3,031 |
Total current assets | 64,292 | 76,803 |
Marketable securities | 0 | 8,811 |
Plant and equipment | ' | ' |
Equipment and furniture | 203,797 | 200,873 |
Leasehold improvements | 46,850 | 46,810 |
Projects in process | 4,832 | 1,964 |
Plant and equipment, gross | 255,479 | 249,647 |
Less accumulated depreciation and amortization | 222,303 | 208,599 |
Plant and equipment, net | 33,176 | 41,048 |
Other assets | 213 | 219 |
Total assets | 97,681 | 126,881 |
Current liabilities: | ' | ' |
Accounts payable | 13,043 | 14,099 |
Accrued liabilities | 4,380 | 4,345 |
Accrued restructuring costs | 245 | 395 |
Total current liabilities | 17,668 | 18,839 |
Other long-term liabilities | 1,604 | 2,017 |
Commitments and contingencies | ' | ' |
Stockholders' equity | ' | ' |
Preferred stock, $0.01 par value, 5,000 shares authorized, none issued or outstanding | 0 | 0 |
Common stock | 844 | 719 |
Additional paid-in capital | 637,922 | 611,279 |
Accumulated deficit | -561,745 | -507,766 |
Accumulated other comprehensive income | 1,647 | 2,052 |
Treasury stock at cost: 115 shares at December 31, 2013 and 2012 | -259 | -259 |
Total stockholders' equity | 78,409 | 106,025 |
Total liabilities and stockholders' equity | 97,681 | 126,881 |
Convertible non-voting stock [Member] | ' | ' |
Stockholders' equity | ' | ' |
Common stock | $0 | $0 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, except Per Share data, unless otherwise specified | ||
Current assets: | ' | ' |
Accounts receivable, net of allowance for doubtful accounts | $172 | $172 |
Stockholders' equity: | ' | ' |
Preferred stock, par value (in dollars per share) | $0.01 | $0.01 |
Preferred stock, authorized (in shares) | 5,000 | 5,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $0.01 | $0.01 |
Common stock, authorized (in shares) | 144,000 | 144,000 |
Common stock, issued (in shares) | 84,437 | 71,853 |
Treasury stock at cost (in shares) | 115 | 115 |
Convertible non-voting stock [Member] | ' | ' |
Stockholders' equity: | ' | ' |
Common stock, par value (in dollars per share) | $0.01 | $0.01 |
Common stock, authorized (in shares) | 1,000 | 1,000 |
Common stock, issued (in shares) | 0 | 0 |
Common stock, outstanding (in shares) | 0 | 0 |
CONSOLIDATED_STATEMENTS_OF_STO
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $) | Common Stock [Member] | Treasury Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] | Accumulated Other Comprehensive Income (Loss) [Member] | Total |
In Thousands, except Share data, unless otherwise specified | ||||||
Balance at Dec. 31, 2010 | $669 | ($259) | $589,562 | ($388,590) | $1,582 | $202,964 |
Balance (in shares) at Dec. 31, 2010 | 66,916,000 | -115,000 | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' |
Stock options exercised | 4 | ' | 931 | ' | ' | 935 |
Stock options exercised (in shares) | 441,000 | ' | ' | ' | ' | ' |
Shares issued under employee stock purchase plan | 4 | ' | 767 | ' | ' | 771 |
Shares issued under employee stock purchase plan (in shares) | 384,000 | ' | ' | ' | ' | ' |
Restricted stock activity, net of forfeitures | 17 | ' | -17 | ' | ' | 0 |
Restricted stock activity, net of forfeitures (in shares) | 1,653,000 | ' | ' | ' | ' | ' |
Amortization of stock-based compensation | ' | ' | 11,514 | ' | ' | 11,514 |
Other comprehensive income (loss) | ' | ' | ' | ' | -336 | -336 |
Net loss | ' | ' | ' | -49,323 | ' | -49,323 |
Balance at Dec. 31, 2011 | 694 | -259 | 602,757 | -437,913 | 1,246 | 166,525 |
Balance (in shares) at Dec. 31, 2011 | 69,394,000 | -115,000 | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' |
Stock options exercised | 10 | ' | 1,913 | ' | ' | 1,923 |
Stock options exercised (in shares) | 950,000 | ' | ' | ' | ' | ' |
Shares issued under employee stock purchase plan | 4 | ' | 823 | ' | ' | 827 |
Shares issued under employee stock purchase plan (in shares) | 407,000 | ' | ' | ' | ' | ' |
Restricted stock activity, net of forfeitures | 11 | ' | -11 | ' | ' | 0 |
Restricted stock activity, net of forfeitures (in shares) | 1,102,000 | ' | ' | ' | ' | ' |
Amortization of stock-based compensation | ' | ' | 5,797 | ' | ' | 5,797 |
Other comprehensive income (loss) | ' | ' | ' | ' | 806 | 806 |
Net loss | ' | ' | ' | -69,853 | ' | -69,853 |
Balance at Dec. 31, 2012 | 719 | -259 | 611,279 | -507,766 | 2,052 | 106,025 |
Balance (in shares) at Dec. 31, 2012 | 71,853,000 | -115,000 | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' |
Issuance of common stock in public offering, net of expenses | 107 | 0 | 19,568 | 0 | 0 | 19,675 |
Issuance of common stock in public offering, net of expenses (in shares) | 10,704,000 | 0 | ' | ' | ' | 10,704 |
Stock options exercised | 0 | ' | 132 | ' | ' | 132 |
Stock options exercised (in shares) | 70,000 | ' | ' | ' | ' | ' |
Shares issued under employee stock purchase plan | 3 | ' | 442 | ' | ' | 445 |
Shares issued under employee stock purchase plan (in shares) | 271,000 | ' | ' | ' | ' | ' |
Restricted stock activity, net of forfeitures | 15 | ' | -15 | ' | ' | 0 |
Restricted stock activity, net of forfeitures (in shares) | 1,539,000 | ' | ' | ' | ' | ' |
Amortization of stock-based compensation | ' | ' | 6,516 | ' | ' | 6,516 |
Other comprehensive income (loss) | ' | ' | ' | ' | -405 | -405 |
Net loss | ' | ' | ' | -53,979 | ' | -53,979 |
Balance at Dec. 31, 2013 | $844 | ($259) | $637,922 | ($561,745) | $1,647 | $78,409 |
Balance (in shares) at Dec. 31, 2013 | 84,437,000 | -115,000 | ' | ' | ' | ' |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
CASH FLOWS FROM OPERATING ACTIVITIES | ' | ' | ' |
Net loss | ($53,979) | ($69,853) | ($49,323) |
Adjustments to reconcile net loss to net cash used in operating activities: | ' | ' | ' |
Depreciation | 14,510 | 16,530 | 18,239 |
Amortization | 97 | 636 | 405 |
Stock based compensation | 6,516 | 5,797 | 11,514 |
Marketable securities recovery and accretion | -1,779 | -1,393 | -208 |
Gain on disposal of equipment | -177 | -89 | -41 |
Changes in operating assets and liabilities: | ' | ' | ' |
Accounts receivable | -2,923 | 5,096 | 17,970 |
Inventories | -2,274 | 893 | 1,001 |
Prepaid expenses and other assets | -433 | 191 | 190 |
Accounts payable | -1,056 | 2,194 | -6,045 |
Accrued and other liabilities | -525 | -3,608 | -2,509 |
Net cash used in operating activities | -42,023 | -43,606 | -8,807 |
CASH FLOWS FROM INVESTING ACTIVITIES | ' | ' | ' |
Purchases of plant and equipment | -6,464 | -2,816 | -5,229 |
Proceeds from sale of equipment | 3 | 47 | 348 |
Purchases of marketable securities | -8,130 | -34,530 | -65,152 |
Proceeds from sales and redemptions of marketable securities | 32,563 | 70,409 | 12,700 |
Net cash provided by (used in) investing activities | 17,972 | 33,110 | -57,333 |
CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' | ' |
Issuances of common stock, net of related costs | 20,252 | 2,750 | 1,706 |
Payment for financing fees | -203 | 0 | 0 |
Net cash provided by financing activities | 20,049 | 2,750 | 1,706 |
Net decrease in cash and cash equivalents | -4,002 | -7,746 | -64,434 |
Cash and cash equivalents at beginning of period | 24,949 | 32,695 | 97,129 |
Cash and cash equivalents at end of period | 20,947 | 24,949 | 32,695 |
Supplemental disclosures of cash flow information: | ' | ' | ' |
Net taxes paid | 133 | 152 | 136 |
Interest paid | $24 | $0 | $0 |
SUMMARY_OF_SIGNIFICANT_ACCOUNT
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | ' | ||||||||||||||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ' | ||||||||||||||||||||||||
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |||||||||||||||||||||||||
NATURE OF OPERATIONS AND BASIS OF PRESENTATION | |||||||||||||||||||||||||
ANADIGICS, Inc. (“the Company”) is a global leader in the design and manufacture of radio frequency semiconductor solutions for cellular, WiFi, and wireless infrastructure and CATV applications. The Company’s product portfolio includes power amplifiers, FEICs, FEMs, and line amplifiers. The Company’s cellular products enable mobile handsets, smartphones, tablets, notebooks, datacards, automotive, M2M, and industrial devices to access 3G and 4G wireless networks utilizing international standards, such as LTE, HSPA, WCDMA, EVDO, CDMA and WiMAX. The Company’s WiFi products enable wireless LAN connectivity for mobile, multimedia and infrastructure devices, such as smartphones, tablets, notebooks, televisions, set-top boxes, modems, routers, and access points. Our solutions are optimized for the latest WiFi standards, including 802.11ac and 802.11n. The Company’s infrastructure solutions include both wireless infrastructure and CATV products. The Company’s wireless infrastructure power amplifiers enable 3G and 4G small-cell base stations, while its CATV products provide the critical link in CATV network infrastructure devices. The Company believes its solutions are well positioned to address these market dynamics and will enable it to outpace the overall end product unit growth in the cellular, WiFi, wireless infrastructure and CATV markets. | |||||||||||||||||||||||||
The Company designs, develops and manufactures RFICs primarily using GaAs compound semiconductor substrates with various process technologies, MESFET, pHEMT, and HBT. The Company’s patented technology, which utilizes InGaP-PlusTM, combines InGaP HBT and pHEMT processes on a single substrate, enabling it to integrate the PA function and the RF active switch function on the same die. The Company fabricates substantially all of its ICs in its six-inch diameter GaAs wafer fabrication facility. | |||||||||||||||||||||||||
The consolidated financial statements include the accounts of ANADIGICS, Inc. and its wholly owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. | |||||||||||||||||||||||||
The Company has evaluated subsequent events and determined that, other than the workforce reduction disclosed in Note 2 and subsequent sale of a former-auction rate security disclosed in Note 4, there were no subsequent events to recognize or disclose in these consolidated financial statements. | |||||||||||||||||||||||||
USE OF ESTIMATES | |||||||||||||||||||||||||
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and the accompanying notes. Actual results could differ from those estimates. Significant estimates that affect the financial statements include, but are not limited to: allowance for doubtful accounts, recoverability and valuation of inventories, warranty reserve, valuation of stock-based compensation, reserves for distributor arrangements and returns, valuation of certain marketable securities, useful lives and amortization periods and recoverability of long-lived assets. | |||||||||||||||||||||||||
CONCENTRATION OF CREDIT RISK | |||||||||||||||||||||||||
The Company grants trade credit to its customers, who are primarily foreign manufacturers of wireless communication devices, cable and broadcast television receivers and fiber optic communication devices. The Company performs periodic credit evaluations of its customers and generally does not require collateral. Sales and accounts receivable from customers are denominated in U.S. dollars. The Company has not experienced significant losses related to receivables from these individual customers. | |||||||||||||||||||||||||
Net sales to individual customers and their affiliates who accounted for 10% or more of the Company’s total net sales and corresponding end application information are as follows: | |||||||||||||||||||||||||
YEAR ENDED DECEMBER 31 | |||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||
Customer (primary application) | $ | % | $ | % | $ | % | |||||||||||||||||||
Samsung Electronics (Cellular / WiFi) | 54,187 | 40 | % | 34,372 | 31 | % | 29,326 | 19 | % | ||||||||||||||||
Huawei Technologies (Cellular) | 15,731 | 12 | % | 15,169 | 14 | % | <10 | % | <10 | % | |||||||||||||||
Murata (WiFi) | 14,274 | 11 | % | <10 | % | <10 | % | <10 | % | <10 | % | ||||||||||||||
ZTE Corporation (Cellular) | <10 | % | <10 | % | 12,818 | 11 | % | 20,416 | 13 | % | |||||||||||||||
Research In Motion Limited (Cellular) | <10 | % | <10 | % | <10 | % | <10 | % | 33,704 | 22 | % | ||||||||||||||
Accounts receivable at December 31, 2013 and 2012 from the greater than 10% customers accounted for 58% and 69% of total accounts receivable, respectively. | |||||||||||||||||||||||||
REVENUE RECOGNITION | |||||||||||||||||||||||||
Revenue from product sales is recognized when title to the products is transferred to the customer, which occurs upon shipment or delivery, depending upon the terms of the sales order. The Company sells to certain distributors who are granted limited contractual rights of return and exchange and certain pre-negotiated individual product-customer price protection. Revenue from sales of products to distributors is recognized, net of allowances, upon shipment of the products to the distributors. At the time of shipment, title transfers to the distributors and payment from the distributors is due on our standard commercial terms; payment terms are not contingent upon resale of the products. Revenue is appropriately reduced for the portion of shipments subject to return, exchange or price protection. Allowances for the distributors are recorded upon shipment and calculated based on the distributors’ indicated intent, historical data, current economic conditions and contractual terms. The Company believes it can reasonably and reliably estimate allowances for credits to distributors in a timely manner. The Company charges customers for the costs of certain contractually-committed inventories that remain at the end of a product's life. Such amounts are recognized as cancellation revenue when cash is received. The value of the inventory related to cancellation revenue may, in some instances, have been reserved during prior periods in accordance with the Company’s inventory obsolescence policy. The Company maintains an allowance for doubtful accounts for estimated losses resulting from customers' failure to make payments. | |||||||||||||||||||||||||
ALLOWANCE FOR DOUBTFUL ACCOUNTS | |||||||||||||||||||||||||
The Company establishes an allowance for doubtful accounts for estimated losses resulting from customers' failure to make payments, based upon historical experience. | |||||||||||||||||||||||||
WARRANTY COSTS | |||||||||||||||||||||||||
The Company provides, by a current charge to income, an amount it estimates, by examining historical returns and other information it deems critical, will be needed to cover future warranty obligations for products sold during the year. The liability for warranty costs is included in Accrued liabilities in the consolidated balance sheets. | |||||||||||||||||||||||||
PLANT AND EQUIPMENT | |||||||||||||||||||||||||
Plant and equipment are stated at cost. Depreciation of plant, furniture and equipment has been provided on the straight-line method over 3-7 years. Leasehold improvements are amortized and included in depreciation over the useful life of the leasehold or the life of the lease, whichever is shorter. | |||||||||||||||||||||||||
IMPAIRMENT OF LONG-LIVED ASSETS | |||||||||||||||||||||||||
Long-lived assets used in operations are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets might not be recoverable. For long-lived assets to be held and used, the Company recognizes an impairment loss if its carrying amount is not recoverable through its undiscounted cash flows and measures the impairment loss based on the difference between the carrying amount and fair value. Long-lived assets held for sale are reported at the lower of cost or fair value less costs to sell. | |||||||||||||||||||||||||
INCOME TAXES | |||||||||||||||||||||||||
Deferred income taxes reflect the net effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the income tax basis of such assets and liabilities. The Company maintains a full valuation allowance on its deferred tax assets. Accordingly, the Company has not recorded a benefit or provision for income taxes. The Company recognizes interest and penalties related to the underpayment of income taxes in income tax expense. No unrecognized tax benefits, interest or penalties were accrued at December 31, 2013 and 2012. The Company’s U.S. federal net operating losses have occurred since 1998 and as such, tax years subject to potential tax examination could apply from that date because carrying-back net operating loss opens the relevant year to audit. | |||||||||||||||||||||||||
RESEARCH AND DEVELOPMENT COSTS | |||||||||||||||||||||||||
The Company charges all research and development costs associated with the development of new products to expense when incurred. | |||||||||||||||||||||||||
CASH EQUIVALENTS | |||||||||||||||||||||||||
The Company considers all highly liquid marketable securities with a maturity of three months or less when purchased to be cash equivalents. | |||||||||||||||||||||||||
MARKETABLE SECURITIES | |||||||||||||||||||||||||
Available for sale securities are stated at fair value, as determined by quoted market prices or as needed, independent valuation models, with unrealized gains and losses reported in other accumulated comprehensive income or loss. Unrealized losses are reviewed and those considered other than temporary are recorded as a charge to other income (expense). Subsequent gains or losses upon redemption or sale of these securities in excess of, or below, their adjusted cost basis are also recorded as other income (expense). The Company considers it more likely than not that it will sell certain auction rate securities prior to a full recovery in valuation. The cost of securities sold is based upon the specific identification method. The amortized cost of securities is adjusted for amortization of premium and accretion of market discounts over the securities’ effective life or maturity and recorded in interest income. See Note 4 for a summary of marketable securities. | |||||||||||||||||||||||||
INVENTORY | |||||||||||||||||||||||||
Inventories are valued at the lower of cost or market ("LCM"), using the first-in, first-out method. The Company capitalizes production overhead costs to inventory on the basis of normal capacity of its production facility and in periods of abnormally low utilization charges the related expenses as a period cost in the statement of operations. In addition to LCM limitations, the Company reserves against inventory items for estimated obsolescence or unmarketable inventory. The reserve for excess and obsolete inventory is primarily based upon forecasted short-term demand for the product. Once established, these write-downs are considered permanent adjustments to the cost basis of the excess inventory. If actual demand and market conditions are less favorable than those projected by management, additional inventory write-downs may be required. In the event the Company sells inventory that had been covered by a specific inventory reserve, the sale is recorded at the actual selling price and the related cost of goods sold at the full inventory cost, net of the reserve. | |||||||||||||||||||||||||
DEFERRED RENT | |||||||||||||||||||||||||
Aggregate rental expense is recognized on a straight-line basis over the lease terms of operating leases that contain predetermined increases in rentals payable during the lease term. | |||||||||||||||||||||||||
FOREIGN CURRENCY TRANSLATION | |||||||||||||||||||||||||
The financial statements of subsidiaries outside of the United States are measured using the local currency as the functional currency. Assets and liabilities of these subsidiaries are translated at the rates of exchange at the balance sheet dates. The resultant translation adjustments are included in other accumulated comprehensive income or loss. Income and expense items are translated at the average monthly rates of exchange. Gains and losses from foreign currency transactions of these subsidiaries are included in the determination of net income or loss. | |||||||||||||||||||||||||
EARNINGS PER SHARE | |||||||||||||||||||||||||
Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised resulting in the issuance of common stock of the Company. Any dilution arising from the Company's outstanding stock awards will not be included where their effect is anti-dilutive. | |||||||||||||||||||||||||
FAIR VALUE OF FINANCIAL INSTRUMENTS | |||||||||||||||||||||||||
The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The fair value of each of the following instruments approximates their carrying value because of the short maturity of these instruments: cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities. See Note 4 for additional fair value disclosures. | |||||||||||||||||||||||||
STOCK-BASED COMPENSATION | |||||||||||||||||||||||||
The Company has various stock-based compensation plans for employees and directors, which are described more fully in Note 10. The Company records stock compensation expense for all stock-based payment awards made to its employees and directors. Stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period which in most cases is the vesting period. | |||||||||||||||||||||||||
RECLASSIFICATIONS | |||||||||||||||||||||||||
Certain prior period amounts have been reclassified to conform to the current presentation. | |||||||||||||||||||||||||
IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS | |||||||||||||||||||||||||
Changes to accounting principles generally accepted in the United States of America (“U.S. GAAP”) are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates to the FASB’s Accounting Standards Codification. | |||||||||||||||||||||||||
In February 2013, the FASB amended its disclosure requirements for those amounts reclassified out of accumulated other comprehensive income. Entities are required to separately disclose each component of other comprehensive income, current period reclassifications out of accumulated other comprehensive income, and other amounts of current-period other comprehensive income. Additional information is required about the effects on net income of significant amounts reclassified out of each component of accumulated other comprehensive income. These additional disclosure requirements are required for reporting periods beginning after December 31, 2012. Adoption of this guidance during the first quarter of 2013 resulted in the Company making the required disclosures in the Notes to its consolidated financial statements. | |||||||||||||||||||||||||
In December 2011, the FASB and International Accounting Standards Board (“IASB”) issued joint requirements related to balance sheet disclosures related to offsetting assets and liabilities. Entities are required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. This scope includes derivatives, sale and repurchase agreements and reverse sale and repurchase agreements, and securities borrowing and securities lending arrangements. The objective of this disclosure is to facilitate comparison between those entities that prepare their financial statements on the basis of U.S. GAAP and those entities that prepare their financial statements on the basis of International Financial Reporting Standards (“IFRS”). Disclosures are required to be retrospective for all comparative periods presented. Adoption of this standard was required in the first quarter of 2013 and did not have a material impact on the Company’s consolidated financial statements. |
RESTRUCTURING_MANAGEMENT_SEPAR
RESTRUCTURING, MANAGEMENT SEPARATION CHARGES, AND SUBSEQUENT EVENT | 12 Months Ended | ||||
Dec. 31, 2013 | |||||
RESTRUCTURING, MANAGEMENT SEPARATION CHARGES, AND SUBSEQUENT EVENT | ' | ||||
RESTRUCTURING, MANAGEMENT SEPARATION CHARGES, AND SUBSEQUENT EVENT | ' | ||||
2. RESTRUCTURING, MANAGEMENT SEPARATION CHARGES, AND SUBSEQUENT EVENT | |||||
RESTRUCTURING | |||||
During 2013, the Company implemented a workforce reduction that eliminated approximately 25 positions throughout the Company which resulted in the Company recording a restructuring charge of $1,915 for severance, related benefits and other costs. | |||||
During 2012 and 2011, the Company implemented workforce reductions that eliminated approximately 40 positions throughout the Company in each year, resulting in restructuring charges of $2,338 and $1,047, respectively, for severance, related benefits and other costs. | |||||
Activity and liability balances related to the restructurings were as follows: | |||||
Accrued | |||||
Restructuring Costs | |||||
December 31, 2011 balance | $ | - | |||
Restructuring expense | 2,338 | ||||
Payments | (1,943 | ) | |||
December 31, 2012 balance | $ | 395 | |||
Restructuring expense | 1,915 | ||||
Payments | (2,065 | ) | |||
December 31, 2013 balance | $ | 245 | |||
MANAGEMENT SEPARATION CHARGES | |||||
During the fourth quarter of 2011, the Company recorded a $4,234 management separation charge, inclusive of accelerated stock-based compensation of $1,775, within Selling and administrative expenses. The management separation charge arose from the resignation of our former Chief Financial Officer, and included contractual separation pay, accelerated vesting of certain equity awards, and certain other costs. | |||||
During the first quarter of 2011, the Company recorded certain management separation charges of $838 and $2,111, inclusive of accelerated stock-based compensation of $568 and $116, within Research and development and Selling and administrative expenses, respectively. The management separation charges arose from the resignations of our former Chief Executive Officer and another Executive Officer, and included contractual separation pay, accelerated vesting of certain equity awards, and certain other costs. | |||||
SUBSEQUENT EVENT | |||||
In February 2014, the Company implemented a workforce reduction that eliminated approximately 40 positions throughout the Company and anticipates recording approximately $1,350 of restructuring charges during the first quarter of 2014 covering severance, related benefits and other costs. |
SEGMENTS
SEGMENTS | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
SEGMENTS [Abstract] | ' | ||||||||||||
SEGMENTS | ' | ||||||||||||
3. SEGMENTS | |||||||||||||
The Company has one reportable segment. Its ICs are primarily manufactured using common manufacturing facilities located in the same domestic geographic area. The method for determining what information to report is based on management’s use of financial information for the purposes of assessing performance and making operating decisions. All operating expenses and assets of the Company are combined and reviewed by the chief operating decision maker on an enterprise-wide basis, resulting in no additional discrete financial information or operating segment information. The Company’s business units share similar long term business models, research and development expenses and selling and administrative expenses. The Company has concluded at December 31, 2013 that it has only one reportable segment. The Company will re-assess its conclusions at least annually. | |||||||||||||
The Company classifies its revenues based upon the end application of the product in which its ICs are used. Net sales by end application are regularly reviewed by the chief operating decision maker and are as follows: | |||||||||||||
Year Ended December 31, | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Cellular | $ | 74,153 | $ | 83,809 | $ | 119,472 | |||||||
Infrastructure | 19,578 | 23,690 | 28,162 | ||||||||||
WiFi | 40,511 | 5,144 | 5,193 | ||||||||||
Total | $ | 134,242 | $ | 112,643 | $ | 152,827 | |||||||
The Company sells to five geographic regions: Asia, Europe, Latin America, USA and Other. The geographic region is determined by the destination of the shipped product. Net sales to each of the five geographic regions are as follows: | |||||||||||||
Year Ended December 31, | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Asia | $ | 125,027 | $ | 92,652 | $ | 102,437 | |||||||
Europe | 1,680 | 3,881 | 14,146 | ||||||||||
Latin America | 5,669 | 9,101 | 29,027 | ||||||||||
USA | 1,865 | 6,601 | 6,934 | ||||||||||
Other | 1 | 408 | 283 | ||||||||||
Total | $ | 134,242 | $ | 112,643 | $ | 152,827 |
FAIR_VALUE_AND_MARKETABLE_SECU
FAIR VALUE AND MARKETABLE SECURITIES | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||
FAIR VALUE AND MARKETABLE SECURITIES [Abstract] | ' | ||||||||||||||||||||
FAIR VALUE AND MARKETABLE SECURITIES | ' | ||||||||||||||||||||
4. FAIR VALUE AND MARKETABLE SECURITIES | |||||||||||||||||||||
FAIR VALUE OF FINANCIAL INSTRUMENTS | |||||||||||||||||||||
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). Inputs used to measure fair value are classified in the following hierarchy: | |||||||||||||||||||||
Level 1 | Unadjusted quoted prices in active markets for identical assets or liabilities | ||||||||||||||||||||
Level 2 | Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability | ||||||||||||||||||||
Level 3 | Unobservable inputs for the asset or liability | ||||||||||||||||||||
The Company endeavors to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following table presents a summary of fair value information for available-for-sale securities: | |||||||||||||||||||||
Fair Value Measurements at Reporting Date Using | |||||||||||||||||||||
Security Type | Amortized | Fair Value | Quoted Prices in | Significant | Significant | ||||||||||||||||
Cost Basis | Active Markets | Other | Unobservable | ||||||||||||||||||
-1 | for Identical | Observable | Inputs | ||||||||||||||||||
Assets | Inputs | (Level 3) | |||||||||||||||||||
(Level 1) | (Level 2) | ||||||||||||||||||||
Fixed Income Securities (2) | $ | 10,235 | $ | 10,240 | $ | - | $ | 10,240 | $ | - | |||||||||||
U.S. Government Agency debt securities (2) | 7,508 | 7,510 | 7,510 | - | - | ||||||||||||||||
Former-auction corporate debt security (3) | 1,740 | 3,078 | - | 3,078 | - | ||||||||||||||||
Auction Rate Securities | |||||||||||||||||||||
Preferred Equity | 2,404 | 4,081 | - | 2,513 | 1,568 | ||||||||||||||||
State and Municipal Debt (3) | 1,394 | 1,652 | - | 1,652 | - | ||||||||||||||||
Total at December 31, 2012 | $ | 23,281 | $ | 26,561 | $ | 7,510 | $ | 17,483 | $ | 1,568 | |||||||||||
Former-auction corporate debt security (3) | $ | 1,800 | $ | 2,997 | $ | - | $ | 2,997 | $ | - | |||||||||||
Auction Rate Security - Preferred Equity | - | 450 | - | - | 450 | ||||||||||||||||
Total at December 31, 2013 | $ | 1,800 | $ | 3,447 | $ | - | $ | 2,997 | $ | 450 | |||||||||||
(1) Difference between amortized cost basis and fair value represents gross unrealized gain or loss. | |||||||||||||||||||||
(2) Available for sale debt securities with contractual maturities of one year or less. | |||||||||||||||||||||
(3) Available for sale debt securities with contractual maturities in excess of 10 years. | |||||||||||||||||||||
AUCTION RATE SECURITIES AND FORMER-AUCTION CORPORATE DEBT SECURITY | |||||||||||||||||||||
Auction rate securities (ARS) were a short-term cash management instrument used by the market and the Company prior to 2008. The instruments used a monthly Dutch auction process to provide liquidity on long-term financial instruments that reset the applicable interest rate and through the reset, allowed existing investors to rollover or liquidate their holdings at par value. During 2007 and early 2008, ARS failed to auction due to sell orders exceeding buy orders. To date, trading continues to be constrained. The funds associated with the failed auctions will not be accessible until a successful auction occurs, a suitable buyer is found outside of the auction process or an issuer redeems its security. The Company considers it more likely than not that it will sell their marketable debt securities prior to a recovery in valuation. | |||||||||||||||||||||
During 2013, two Level 2 and one Level 3 ARS redeemed for $6,739, resulting in a realized gain of $1,684, which was recorded to Other income, net. In January 2014, the Level 2 former-auction corporate debt security was sold for $2,960, resulting in a realized gain of $1,160 to be recorded in the first quarter of 2014 to Other income, net. | |||||||||||||||||||||
Certain ARS market information was insufficient to determine the fair value of the Company’s investments in ARS resulting in Level 2 and Level 3 valuations. Given the complexity of ARS investments, the Company obtained the assistance of an independent valuation firm to assist management in assessing the fair value of its ARS portfolio in fiscal years 2012 and 2011. The third party valuations developed to estimate the ARS fair value were determined using a combination of two calculations (1) a discounted cash flow (DCF) model, where the expected cash flows of the ARS are discounted to the present using a yield that incorporates compensation for illiquidity, and (2) a market comparables (MC) method, where the ARS are valued based on indications, from the secondary market, of what discounts buyers demand when purchasing similar ARS. The valuations include numerous assumptions such as assessments of the underlying structure of each security, expected cash flows, discount rates, credit ratings, workout periods, and overall capital market liquidity. | |||||||||||||||||||||
Interest income of $93 and $118 was recognized to accrete the amortized cost basis of the Company’s existing and former-auction debt securities during the years ended December 31, 2013 and 2012, respectively. | |||||||||||||||||||||
The table below provides a reconciliation of the beginning and ending balances for each type of security valued using a Level 3 valuation. | |||||||||||||||||||||
($ in 000’s) | Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||
Years ended December 31, 2012 and 2013 | |||||||||||||||||||||
Corporate | Preferred Equity Security | Total | |||||||||||||||||||
Debt | Monoline insurers (b) | ||||||||||||||||||||
Security (a) | |||||||||||||||||||||
Balance at December 31, 2011 | $ | 1,215 | $ | 628 | $ | 1,843 | |||||||||||||||
Transfers out of Level 3 | - | - | - | ||||||||||||||||||
Total gains or losses realized/unrealized | |||||||||||||||||||||
Included in net loss | 1,250 | - | 1,250 | ||||||||||||||||||
Included in other comprehensive income | (452 | ) | 940 | 488 | |||||||||||||||||
Redemptions | (2,013 | ) | - | (2,013 | ) | ||||||||||||||||
Ending Balance December 31, 2012 | $ | - | $ | 1,568 | $ | 1,568 | |||||||||||||||
Transfers out of Level 3 | - | - | - | ||||||||||||||||||
Total gains or losses realized/unrealized | |||||||||||||||||||||
Included in net loss | - | 872 | 872 | ||||||||||||||||||
Included in other comprehensive income | - | 10 | 10 | ||||||||||||||||||
Redemptions | - | (2,000 | ) | (2,000 | ) | ||||||||||||||||
Ending Balance December 31, 2013 | $ | - | $ | 450 | $ | 450 | |||||||||||||||
Amount of total gains or losses for the period included in earnings(loss) attributable to the change in unrealized gains or losses relating to Level 3 assets still held at the reporting date | $ | - | $ | - | $ | - | |||||||||||||||
Level 3 security held at December 31, 2013: | |||||||||||||||||||||
Face value | - | $ | 1,125 | $ | 1,125 | ||||||||||||||||
Financial ratings | - | NR | |||||||||||||||||||
Weighted average interest rate (*) | - | 0 | % | 0 | % | ||||||||||||||||
Maturity date | - | N/ | A | ||||||||||||||||||
(a) Security issued by a publicly-held insurance company trust, which holds investments in U.S. Government obligations, highly rated commercial paper and money market funds and other investments approved by two credit rating agencies. The $2,500 face value security was redeemed by the issuer at a discount in the first quarter of 2012 for $2,013, resulting in a gain over its amortized cost basis of $1,250. | |||||||||||||||||||||
(b) Preferred securities issued by subsidiaries of two publicly-held debt default insurers. During the second quarter of 2013, one of these securities redeemed at $2,000 par, resulting in an $872 realized gain recorded to Other income, net. |
INVENTORIES
INVENTORIES | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
INVENTORIES [Abstract] | ' | ||||||||
INVENTORIES | ' | ||||||||
5. INVENTORIES | |||||||||
Inventories consist of the following: | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Raw materials | $ | 7,323 | $ | 5,108 | |||||
Work in progress | 8,424 | 9,781 | |||||||
Finished goods | 5,367 | 3,951 | |||||||
Total | $ | 21,114 | $ | 18,840 |
ACCRUED_LIABILITIES
ACCRUED LIABILITIES | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
ACCRUED LIABILITIES [Abstract] | ' | ||||||||||||
ACCRUED LIABILITIES | ' | ||||||||||||
6. ACCRUED LIABILITIES | |||||||||||||
Accrued liabilities consist of the following: | |||||||||||||
December 31, | |||||||||||||
2013 | 2012 | ||||||||||||
Accrued compensation | $ | 1,844 | $ | 1,945 | |||||||||
Warranty reserve | 383 | 770 | |||||||||||
Other | 2,153 | 1,630 | |||||||||||
$ | 4,380 | $ | 4,345 | ||||||||||
Changes in the Company’s product warranty reserve are as follows: | |||||||||||||
Year ended December 31 | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Beginning balance | $ | 770 | $ | 430 | $ | 571 | |||||||
Additions charged to costs and expenses | 554 | 1,507 | 871 | ||||||||||
Claims processed | (941 | ) | (1,167 | ) | (1,012 | ) | |||||||
Ending balance | $ | 383 | $ | 770 | $ | 430 |
COMMITMENTS_AND_CONTIGENCIES
COMMITMENTS AND CONTIGENCIES | 12 Months Ended | ||||
Dec. 31, 2013 | |||||
COMMITMENTS AND CONTINGENCIES [Abstract] | ' | ||||
COMMITMENTS AND CONTINGENCIES | ' | ||||
7. COMMITMENTS AND CONTINGENCIES | |||||
The Company leases manufacturing, warehousing and office space under noncancelable operating leases that expire through 2016. Rent expense was $2,350, $2,567, $2,617, in 2013, 2012 and 2011, respectively. At December 31, 2013 and 2012, there were no capital lease obligations outstanding. The future minimum lease payments under the noncancelable operating leases, excluding deferred rent adjustments. are as follows: | |||||
YEAR | Operating | ||||
Leases | |||||
2014 | $ | 2,783 | |||
2015 | 2,630 | ||||
2016 | 2,408 | ||||
2017 | 210 | ||||
2018 | 131 | ||||
Thereafter | 11 | ||||
Total minimum lease payments | $ | 8,173 | |||
In addition to the above, at December 31, 2013, the Company had unconditional purchase obligations of approximately $2,073. |
INCOME_TAXES
INCOME TAXES | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
INCOME TAXES [Abstract] | ' | ||||||||||||||||||||||||
INCOME TAXES | ' | ||||||||||||||||||||||||
8. INCOME TAXES | |||||||||||||||||||||||||
There were no current and deferred components of income taxes for the years ended December 31, 2013, 2012, and 2011. | |||||||||||||||||||||||||
Deferred tax assets require a valuation allowance when, in the opinion of management, it is more likely than not that some portion of the deferred tax assets may not be realized. Whereas realization of the deferred tax assets is dependent upon the timing and magnitude of future taxable income prior to the expiration of the deferred tax attributes, management began recording a full valuation allowance in 2001. The amount of the deferred tax assets considered realizable, however, could change if estimates of future taxable income during the carry-forward period are changed. | |||||||||||||||||||||||||
Significant components of the Company’s net deferred taxes as of December 31, 2013 and 2012 are as follows: | |||||||||||||||||||||||||
December 31, | |||||||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||||||
Deferred tax balances | |||||||||||||||||||||||||
Accruals/reserves | $ | 7,652 | $ | 9,091 | |||||||||||||||||||||
Net operating loss carryforwards | 210,894 | 181,815 | |||||||||||||||||||||||
Research and experimentation credits | 14,414 | 14,086 | |||||||||||||||||||||||
Deferred rent expense | 614 | 772 | |||||||||||||||||||||||
Difference in basis of plant and equipment | 9,791 | 9,483 | |||||||||||||||||||||||
Valuation allowance | (243,365 | ) | (215,247 | ) | |||||||||||||||||||||
Net deferred tax assets | - | - | |||||||||||||||||||||||
As of December 31, 2013, the Company had net operating loss carryforwards of approximately $578,346 for federal and $290,117 for state tax reporting purposes. The federal carryforward will begin to expire in 2019, and the state carryforwards have begun to expire. A portion of net operating loss carryforwards and tax credit carryforwards may be subject to an annual limitation regarding their utilization against taxable income in future periods due to the “change of ownership” provisions of the Internal Revenue Code and similar state provisions. A portion of these carryforwards may expire before becoming available to reduce future income tax liabilities. | |||||||||||||||||||||||||
At December 31, 2013, $25,149 of the deferred tax asset related to net operating loss carryforwards and an equivalent amount of deferred tax asset valuation allowance represented tax benefits associated with the exercise of non-qualified stock options and vesting of restricted stock deduction over book. Such benefit, when realized, will be credited to additional paid-in capital. Included within the Company’s net operating loss tax carryforwards at December 31, 2013, the Company has excess tax benefits, related to stock-based compensation of $16,005 which are not recorded as a deferred tax asset as the amounts would not have resulted in a reduction in current taxes payable until all other tax attributes currently available to the Company were utilized. The benefit of these deductions will be recorded to additional paid-in capital at the time the tax deduction results in a reduction of current taxes payable. | |||||||||||||||||||||||||
The earnings associated with the Company’s investment in its foreign subsidiaries are considered to be permanently invested and no provision for U.S. federal and state income taxes on those earnings or translation adjustments has been provided. | |||||||||||||||||||||||||
The reconciliation of income tax expense computed at the U.S. federal statutory rate to the benefit from income taxes is as follows: | |||||||||||||||||||||||||
Year Ended December 31, | |||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||
Tax at U.S. statutory rate | $ | (18,893 | ) | (35.0 | )% | $ | (24,448 | ) | (35.0 | )% | $ | (17,263 | ) | (35.0 | )% | ||||||||||
Effect of permanent items | 6 | - | 163 | 0.2 | (2 | ) | - | ||||||||||||||||||
State and foreign tax (benefit), net of federal tax effect | (1,754 | ) | (3.2 | ) | (2,255 | ) | (3.2 | ) | (1,603 | ) | (3.3 | ) | |||||||||||||
Research and experimentation tax credits, net | (328 | ) | (0.6 | ) | (33 | ) | (0.1 | ) | (68 | ) | (0.1 | ) | |||||||||||||
Valuation allowance, net | 28,118 | 52.1 | 23,802 | 34.1 | 16,181 | 32.8 | |||||||||||||||||||
Worthless stock deduction | (4,997 | ) | (9.3 | ) | - | - | - | - | |||||||||||||||||
Other | (2,152 | ) | (4.0 | ) | 2,771 | 4 | 2,755 | 5.6 | |||||||||||||||||
(Benefit from) provision for income taxes | $ | - | - | % | $ | - | - | % | $ | - | - | % |
STOCKHOLDERS_EQUITY
STOCKHOLDERS' EQUITY | 12 Months Ended |
Dec. 31, 2013 | |
STOCKHOLDERS' EQUITY [Abstract] | ' |
STOCKHOLDERS' EQUITY | ' |
9. STOCKHOLDERS' EQUITY | |
In March 2013, the Company completed an underwritten public offering of 10,704 shares of common stock at a price of $2.00 per share which generated net proceeds to the Company of $19,675. | |
On December 17, 1998, the Company adopted a Shareholders’ Rights Agreement (“the Agreement”). Pursuant to the Agreement, as amended on November 30, 2000 and October 2, 2008, rights were distributed as a dividend at the rate of one right for each share of ANADIGICS, Inc. common stock, par value $0.01 per share, held by stockholders of record as of the close of business on December 31, 1998. The rights will expire on December 17, 2018, unless earlier redeemed or exchanged. Under the Agreement, each right will entitle the registered holder to buy one one-thousandth of a share of Series A Junior Participating Preferred Stock at a price of $75.00 per one one-thousandth of a share, subject to adjustment in accordance with the Agreement. The rights will become exercisable only if a person or group of affiliated or associated persons acquires, or obtains the right to acquire, beneficial ownership of ANADIGICS, Inc. common stock or other voting securities that have 18% or more of the voting power of the outstanding shares of voting stock, or upon the commencement or announcement of an intention to make a tender offer or exchange offer, the consummation of which would result in such person or group acquiring, or obtaining the right to acquire, beneficial ownership of 18% or more of the voting power of ANADIGICS, Inc. common stock or other voting securities. |
EMPLOYEE_BENEFIT_PLANS
EMPLOYEE BENEFIT PLANS | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
EMPLOYEE BENEFIT PLANS [Abstract] | ' | ||||||||||||||||||||||||
EMPLOYEE BENEFIT PLANS | ' | ||||||||||||||||||||||||
10. EMPLOYEE BENEFIT PLANS | |||||||||||||||||||||||||
The Company records stock-based compensation expense for all stock-based payment awards made to our employees and directors. Stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period which in most cases is the vesting period. | |||||||||||||||||||||||||
Equity Compensation Plans | |||||||||||||||||||||||||
The Company has two active equity compensation plans under which equity securities are authorized for issuance to employees and/or directors and two plans (the 1995 Plan and 1997 Plan, described below) which have been terminated: | |||||||||||||||||||||||||
§ | The 1995 Long-Term Incentive and Share Award Plan for Officers and Directors (terminated February 28, 2005) (1995 Plan); | ||||||||||||||||||||||||
§ | The 1997 Long Term Incentive and Share Award Plan (terminated February 28, 2005) (1997 Plan); | ||||||||||||||||||||||||
§ | The 2005 Long Term Incentive and Share Award Plan (2005 Plan, collectively with the 1995 Plan and the 1997 Plan, the Plans); and | ||||||||||||||||||||||||
§ | The Employee Stock Purchase Plan (ESP Plan). | ||||||||||||||||||||||||
Employees and outside directors have been granted restricted stock shares or units (collectively, restricted stock) and options to purchase shares of common stock under the Plans. An aggregate of 4,913, 5,100 and 24,850 shares of common stock were reserved for issuance under the 1995 Plan, the 1997 Plan and the 2005 Plan, respectively. The Plans provide for the granting of stock options, stock appreciation rights, restricted stock and other share based awards to eligible employees and directors, as defined in the Plans. Option grants have terms of 10 years and become exercisable in varying amounts over periods of up to three years. To date, no stock appreciation rights have been granted under the Plans. | |||||||||||||||||||||||||
In 1995, the Company adopted the ESP Plan under Section 423 of the Internal Revenue Code. All full-time and part-time Company employees, as defined in the ESP Plan, are eligible to participate in the ESP Plan. An aggregate of 6,694 shares of common stock were reserved for offering under the ESP Plan. Offerings are made at the commencement of each calendar year and must be purchased by the end of that calendar year. Pursuant to the terms of the ESP Plan, shares purchased and the applicable per share price were 271 ($1.64), 407 ($2.04) and 384 ($2.00) for the years ended December 31, 2013, 2012 and 2011, respectively. | |||||||||||||||||||||||||
Stock-based compensation expense arises from the amortization of restricted stock grants, unamortized stock option grants and from the ESP Plan. The Company uses the straight-line basis in calculating stock-based compensation expense. | |||||||||||||||||||||||||
The table below summarizes stock-based compensation by source and by financial statement line item: | |||||||||||||||||||||||||
For years ended December 31, | |||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||
Amortization of restricted stock awards | $ | 6,239 | $ | 4,813 | $ | 9,308 | |||||||||||||||||||
Amortization of ESP Plan | 149 | 314 | 307 | ||||||||||||||||||||||
Amortization of stock option awards | 128 | 670 | 1,899 | ||||||||||||||||||||||
Total stock-based compensation | $ | 6,516 | $ | 5,797 | $ | 11,514 | |||||||||||||||||||
By Financial Statement line item | |||||||||||||||||||||||||
Cost of sales | $ | 1,041 | $ | 888 | $ | 1,798 | |||||||||||||||||||
Research and development expenses | 2,118 | 1,626 | 2,981 | ||||||||||||||||||||||
Selling and administrative expenses | 3,428 | 3,218 | 6,815 | ||||||||||||||||||||||
Restructuring charges | (71 | ) | 65 | (80 | ) | ||||||||||||||||||||
No tax benefits have been recorded due to the Company’s full valuation allowance position. | |||||||||||||||||||||||||
Restricted Stock Awards | |||||||||||||||||||||||||
Under the Plans, the Company grants restricted stock shares and units to its employees. The value of restricted stock grants are fixed upon the date of grant and amortized over the related vesting period, primarily ranging up to three years. Restricted stock is subject to forfeiture if employment terminates prior to vesting. The Company estimates that approximately 2.5% of its restricted stock and option awards are forfeited annually (exclusive of performance-based restricted stock awards and performance-based option shares, as described below). The restricted stock shares carry voting and certain forfeitable dividend rights commencing upon grant, whereas restricted stock units do not. Neither restricted stock shares nor restricted stock units may be traded or transferred prior to vesting. Grant, vest and forfeit activity and related weighted average (WA) price per share for restricted stock and for stock options during the period from January 1, 2011 to December 31, 2013 is presented in tabular form below: | |||||||||||||||||||||||||
Restricted Stock | Restricted Stock | Stock | |||||||||||||||||||||||
Shares | Units | Options | |||||||||||||||||||||||
Shares | WA price per share | Units | WA price per unit | Issuable upon exercise | WA exercise price | ||||||||||||||||||||
Shares outstanding at December 31, 2010 | 180 | $ | 8.39 | 1,460 | $ | 4.49 | 4,143 | $ | 4.96 | ||||||||||||||||
Granted (1) | - | - | 2,573 | 5.91 | 1,065 | 3.29 | |||||||||||||||||||
Shares vested/options exercised | (179 | ) | 8.38 | (1,654 | ) | 5.08 | (442 | ) | 2.12 | ||||||||||||||||
Forfeited/expired (2) | (1 | ) | 9.72 | (409 | ) | 6.03 | (491 | ) | 9.37 | ||||||||||||||||
Balance at December 31, 2011 | - | - | 1,970 | $ | 5.52 | 4,275 | $ | 4.32 | |||||||||||||||||
Granted | - | - | 661 | 2.32 | 13 | 1.97 | |||||||||||||||||||
Shares vested/options exercised | - | - | (1,102 | ) | 4.69 | (950 | ) | 2.02 | |||||||||||||||||
Forfeited/expired (2) | - | - | (99 | ) | 6.21 | (843 | ) | 5.21 | |||||||||||||||||
Balance at December 31, 2012 | - | - | 1,430 | $ | 4.63 | 2,495 | $ | 4.89 | |||||||||||||||||
Granted (1) | - | - | 3,509 | 2.11 | 13 | 2.26 | |||||||||||||||||||
Shares vested/options exercised | - | - | (1,539 | ) | 3.34 | (69 | ) | 1.93 | |||||||||||||||||
Forfeited/expired (2,3) | - | - | (528 | ) | 2.5 | (480 | ) | 3.99 | |||||||||||||||||
Balance at December 31, 2013 | - | - | 2,872 | $ | 2.63 | 1,959 | $ | 5.2 | |||||||||||||||||
-1 | Year 2011 stock options granted include 417 performance-based stock option shares; | ||||||||||||||||||||||||
Year 2013 restricted stock units granted include 560 performance-based restricted stock units. | |||||||||||||||||||||||||
-2 | Years 2011, 2012, and 2013 stock options forfeited include 167, 83 and 42 performance-based option shares, respectively; Year 2013 restricted stock units forfeited include 384 performance-based units. | ||||||||||||||||||||||||
-3 | In the second quarter of 2013, 125 time-based and 83 (125 at maximum performance achievement) performance-based stock options were rescinded with the consent of and without payment to the CEO due to the fact that the original grants with respect to which these options were a part of exceeded the sub-limits of the applicable plan by the number of shares as to which the options were rescinded. | ||||||||||||||||||||||||
. | |||||||||||||||||||||||||
Exercisable options and their related average exercise prices were 1,840 ($5.33), 2,011 ($5.27) and 3,485 ($4.55) as of December 31, 2013, 2012 and 2011, respectively. | |||||||||||||||||||||||||
In June 2011, the Company’s Chief Executive Officer and then Chief Financial Officer were awarded a base grant of 417 performance-based stock options contingent upon the Company’s shareholder return performance against the performance of the Philadelphia Semiconductor Index component companies. Following the rescission discussed in footnote (6) in the table immediately above, the base grant was reduced by 83 performance-based stock options during the second quarter of 2013. The award and performance will be evaluated annually in one-third increments measuring Company shareholder returns during the one, two and three year periods following the award. Depending upon performance, the number of shares issuable pursuant to the performance-based stock options can range from 50% to 150% of the base option shares. Company performance below the 25th-percentile in a measurement period would result in no vesting for that period. The performance-based stock options have an exercise price of $3.24, expire 10 years after the grant date, and had an average fair value of $2.62 on the date of grant. The fair value estimate was calculated with the assistance of a valuation consultant using a Monte Carlo Simulation model. During the fourth quarter of 2011, 167 shares the performance-based stock options were forfeited upon the separation of our former Chief Financial Officer. In the second quarters of 2012 and 2013, 83 and 42 shares, respectively, were canceled for non-achievement of performance goals at the end of the first and second measurement periods. | |||||||||||||||||||||||||
On February 16, 2012, subject to stockholder approval of additional 2005 Long-Term Incentive and Share Award Plan shares at the Company’s 2013 Annual Stockholder Meeting (at which such approval was received), the Company awarded 661 time-based and 220 performance-based restricted stock units to its officers and employees. The time-based restricted stock units vested one-third on May 20, 2013, and vest one-third on February 18, 2014 and one-third on February 18, 2015. The performance-based restricted stock units vest based on absolute total stockholder return for one-year, two-year and three-year periods starting from the baseline date of December 31, 2011, compared to total stockholder return targets for each of the respective periods. As of December 31, 2013, the performance metrics for the first and second year periods were not met on the performance-based awards. | |||||||||||||||||||||||||
On December 4, 2012, subject to stockholder approval of additional 2005 Long-Term Incentive and Share Award Plan shares at the Company’s 2013 Annual Stockholder Meeting (at which such approval was received), the Company awarded 660 restricted stock units to its officers and other key employees (subsequently increased by 20 to an additional officer in July 2013). Fifty percent of these restricted stock units have time-based vesting conditions and 50% have performance-based vesting conditions. The restricted stock units vest one-third annually in May 2014, 2015, and 2016 (August 2014, 2015 and 2016 vest for the July 2013 grant). The performance-based awards were evaluated based on the Company’s adjusted cash flow from operations for the year ended December 31, 2013, with 34.8% of the performance metrics achieved and 111 total units issuable over the specified vest periods. | |||||||||||||||||||||||||
The total fair value of restricted stock vested during the years ended December 31, 2013, 2012 and 2011 were $3,052, $2,208 and $6,942, respectively. The intrinsic value of exercised options during the years ended December 31, 2013, 2012 and 2011 were $14, $512 and $787, respectively. | |||||||||||||||||||||||||
Weighted average information as of | |||||||||||||||||||||||||
31-Dec-13 | |||||||||||||||||||||||||
Options currently exercisable | |||||||||||||||||||||||||
Shares issuable upon exercise | 1,840 | ||||||||||||||||||||||||
Weighted average exercise price | $ | 5.33 | |||||||||||||||||||||||
Weighted average remaining contractual term | 3.0 years | ||||||||||||||||||||||||
Weighted average remaining contractual term for outstanding options | 3.3 years | ||||||||||||||||||||||||
Intrinsic value of exercisable options | $ | 1 | |||||||||||||||||||||||
Intrinsic value of outstanding options | $ | 2 | |||||||||||||||||||||||
Unrecognized stock-based compensation cost | |||||||||||||||||||||||||
Option plans | $ | 109 | |||||||||||||||||||||||
Restricted stock | $ | 3,304 | |||||||||||||||||||||||
Weighted average remaining vest period for option plans | 0.7 years | ||||||||||||||||||||||||
Weighted average remaining vest period for restricted stock | 1.3 years | ||||||||||||||||||||||||
Stock options outstanding at December 31, 2013 are summarized as follows: | |||||||||||||||||||||||||
Range of exercise prices | Outstanding | Weighted | Weighted | Exercisable at | Weighted | ||||||||||||||||||||
Options at | average | average | December 31, | average exercise | |||||||||||||||||||||
December 31, | remaining | exercise | 2013 | price | |||||||||||||||||||||
2013 | contractual life | price | |||||||||||||||||||||||
$ | 1.23 - $1.93 | 646 | 3.7 | $ | 1.93 | 641 | $ | 1.93 | |||||||||||||||||
$ | 2.00 - $3.24 | 322 | 7.3 | $ | 3.18 | 209 | $ | 3.19 | |||||||||||||||||
$ | 3.30 - $8.79 | 493 | 1 | $ | 6.56 | 492 | $ | 6.56 | |||||||||||||||||
$ | 8.84 - $18.98 | 498 | 2.4 | $ | 9.4 | 498 | $ | 9.4 | |||||||||||||||||
Valuation for ESP Plan and Stock Option Awards | |||||||||||||||||||||||||
The fair value of these equity awards was estimated at the date of grant using a Black-Scholes option pricing model. The weighted average assumptions and fair values for stock-based compensation grants used for the years ended December 31, 2013, 2012 and 2011 are summarized below (excludes the aforementioned performance-based option grants). | |||||||||||||||||||||||||
Year ended December 31, | |||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||
Stock option awards: | |||||||||||||||||||||||||
Risk-free interest rate | 0.8 | % | 1 | % | 2.2 | % | |||||||||||||||||||
Expected volatility | 72 | % | 70 | % | 65 | % | |||||||||||||||||||
Average expected term (in years) | 5 | 5 | 5 | ||||||||||||||||||||||
Expected dividend yield | 0 | % | 0 | % | 0 | % | |||||||||||||||||||
Weighted average fair value of options granted | $ | 1.36 | $ | 1.14 | $ | 1.85 | |||||||||||||||||||
ESP Plan: | |||||||||||||||||||||||||
Risk-free interest rate | 0.1 | % | 0.2 | % | 0.1 | % | |||||||||||||||||||
Expected volatility | 51 | % | 61 | % | 66 | % | |||||||||||||||||||
Average expected term | 1 | 1 | 1 | ||||||||||||||||||||||
Expected dividend yield | 0 | % | 0 | % | 0 | % | |||||||||||||||||||
Weighted average fair value of purchase option | $ | 0.55 | $ | 0.77 | $ | 0.8 | |||||||||||||||||||
The Company regularly assesses the assumptions used in its option valuation. For equity awards with an expected term of one year or less, the assumption for expected volatility is solely based on the Company’s historical volatility. For equity awards with expected terms of greater than one year, the Company used a combination of implied and historical volatility for options granted in the years ended December 31, 2013, 2012 and 2011. The expected term of the stock options is based on historical observations of employee exercise patterns combined with expectations of employee exercise behavior in the future giving consideration to the contractual terms of the stock-based awards. The risk free interest rate assumption has consistently been based on the yield at the time of grant of a U.S. Treasury security with an equivalent remaining term. The Company has never paid cash dividends and does not currently intend to pay cash dividends and has consistently assumed a 0% dividend yield. | |||||||||||||||||||||||||
The Company also sponsors an Employee Savings and Protection Plan under Section 401(k) of the Internal Revenue Code which is available to all full-time employees. Employees can make voluntary contributions up to limitations prescribed by the Internal Revenue Code. The Company matches 30% of employee contributions up to 10% of their gross pay. The Company recorded expense relating to plan contributions of $829, $855, and $928 for the years ended December 31, 2013, 2012 and 2011, respectively. |
LOSS_PER_SHARE
LOSS PER SHARE | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
LOSS PER SHARE [Abstract] | ' | ||||||||||||
LOSS PER SHARE | ' | ||||||||||||
11. LOSS PER SHARE | |||||||||||||
The reconciliation of shares used to calculate basic and diluted loss per share consists of the following: | |||||||||||||
Year ended December 31, | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Weighted average common shares for basic loss per share | 80,991 | 70,721 | 67,771 | ||||||||||
Effect of dilutive securities: | |||||||||||||
Stock options (*) | - | - | - | ||||||||||
Unvested restricted stock (*) | - | - | - | ||||||||||
Adjusted weighted average shares for diluted loss per share | 80,991 | 70,721 | 67,771 | ||||||||||
* | Incremental shares from restricted stock and stock options are computed using the treasury stock method. | ||||||||||||
Dilution arising from the Company's outstanding stock options or unvested restricted stock was not included in the years ended December 31, 2013, 2012 and 2011 as their effect was anti-dilutive. Potential dilution arising from any of the remainder of the Company's outstanding stock options or unvested restricted stock is detailed below. Such potential dilution was excluded as their effect was anti-dilutive. | |||||||||||||
Year ended December 31, | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Stock options | 1,959 | 2,495 | 4,275 | ||||||||||
Unvested restricted stock | 2,872 | 1,430 | 1,970 |
OTHER_ACCUMULATED_COMPREHENSIV
OTHER ACCUMULATED COMPREHENSIVE INCOME | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
OTHER ACCUMULATED COMPREHENSIVE INCOME [Abstract] | ' | ||||||||||||
OTHER ACCUMULATED COMPREHENSIVE INCOME | ' | ||||||||||||
12. OTHER ACCUMULATED COMPREHENSIVE INCOME | |||||||||||||
The components of other accumulated comprehensive income are as follows: | |||||||||||||
Net Unrealized Gain (Loss) on Marketable Securities | Foreign Currency Translation | Total | |||||||||||
Balance at December 31, 2011 | $ | 1,255 | $ | (9 | ) | $ | 1,246 | ||||||
Other comprehensive income before reclassifications | 2,193 | 6 | 2,199 | ||||||||||
Amounts reclassified from accumulated other comprehensive income * | (1,393 | ) | - | (1,393 | ) | ||||||||
Net current period other comprehensive income | 800 | 6 | 806 | ||||||||||
Balance at December 31, 2012 | $ | 2,055 | $ | (3 | ) | $ | 2,052 | ||||||
Other comprehensive income before reclassifications | 1,371 | 3 | 1,374 | ||||||||||
Amounts reclassified from accumulated other comprehensive income * | (1,779 | ) | - | (1,779 | ) | ||||||||
Net current period other comprehensive income | (408 | ) | 3 | (405 | ) | ||||||||
Balance at December 31, 2013 | $ | 1,647 | $ | - | $ | 1,647 | |||||||
* Amounts reclassified are recorded within Other income, net in the Consolidated Statements of Operations |
LINE_OF_CREDIT
LINE OF CREDIT | 12 Months Ended |
Dec. 31, 2013 | |
LINE OF CREDIT [Abstract] | ' |
LINE OF CREDIT | ' |
13. LINE OF CREDIT | |
In April 2013, the Company entered into a Revolving Credit and Security Agreement (the “Agreement”) with PNC Bank, N.A., which Agreement was amended in December 2013 to revise the minimum EBITDA covenants. The Agreement provides the Company with a three-year revolving credit facility of $11,000 that expires on April 30, 2016. The facility is secured by certain cash balances with borrowing availability based upon Accounts receivable and compliance with covenants, including minimum EBITDA (as defined in the Agreement) and certain capital expenditure limits. The Company may elect to borrow at rates approximating LIBOR plus 3.25%. The Agreement contains a fee for any unused portion of the facility. As of December 31, 2013, the Company was in compliance with its covenants and there were no amounts outstanding under the Agreement. |
LEGAL_PROCEEDINGS
LEGAL PROCEEDINGS | 12 Months Ended |
Dec. 31, 2013 | |
LEGAL PROCEEDINGS [Abstract] | ' |
LEGAL PROCEEDINGS | ' |
14. LEGAL PROCEEDINGS | |
The Company is a party to ordinary course litigation arising out of the operation of our business. The Company believes that the ultimate resolution of such ordinary course litigation should not have a material adverse effect on its consolidated financial condition or results of operations. |
QUARTERLY_FINANCIAL_DATA_UNAUD
QUARTERLY FINANCIAL DATA (UNAUDITED) | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||||||||||
QUARTERLY FINANCIAL DATA (UNAUDITED) [Abstract] | ' | ||||||||||||||||||||||||||||||||
QUARTERLY FINANCIAL DATA (UNAUDITED) | ' | ||||||||||||||||||||||||||||||||
15. QUARTERLY FINANCIAL DATA (UNAUDITED) | |||||||||||||||||||||||||||||||||
2013 and 2012 Quarterly Financial Data | |||||||||||||||||||||||||||||||||
The following table sets forth certain unaudited results of operations for each quarter during 2013 and 2012. The unaudited information has been prepared on the same basis as the audited consolidated financial statements and includes all adjustments which management considers necessary for a fair presentation of the financial data shown. The operating results for any quarter are not necessarily indicative of the results to be attained for any future period. Basic and diluted loss per share are computed independently for each of the periods presented. Accordingly, the sum of the quarterly loss per share may not agree to the total for the year (in thousands, except for per share data). | |||||||||||||||||||||||||||||||||
Quarter Ended | |||||||||||||||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||||||||||||||
Dec. 31 | Sep. 28 | 29-Jun | Mar. 30 | Dec. 31 | Sep. 29 | 30-Jun | Mar. 31 | ||||||||||||||||||||||||||
Net sales | $ | 36,286 | $ | 37,011 | $ | 34,565 | $ | 26,380 | $ | 30,476 | $ | 28,642 | $ | 25,099 | $ | 28,426 | |||||||||||||||||
Cost of sales | 31,640 | 32,912 | 34,269 | 27,101 | 31,017 | 28,809 | 27,296 | 26,747 | |||||||||||||||||||||||||
Gross profit (loss) | 4,646 | 4,099 | 296 | (721 | ) | (541 | ) | (167 | ) | (2,197 | ) | 1,679 | |||||||||||||||||||||
Research and development expenses | 9,321 | 9,551 | 9,433 | 10,280 | 10,145 | 10,823 | 11,310 | 11,614 | |||||||||||||||||||||||||
Selling and administrative expense | 5,574 | 5,782 | 6,215 | 6,242 | 5,516 | 5,597 | 6,321 | 6,855 | |||||||||||||||||||||||||
Restructuring charges | - | - | - | 1,915 | - | 605 | 1,239 | 494 | |||||||||||||||||||||||||
Operating loss | (10,249 | ) | (11,234 | ) | (15,352 | ) | (19,158 | ) | (16,202 | ) | (17,192 | ) | (21,067 | ) | (17,284 | ) | |||||||||||||||||
Interest income | 33 | 46 | 65 | 93 | 117 | 128 | 133 | 150 | |||||||||||||||||||||||||
Interest expense | (31 | ) | (31 | ) | (20 | ) | - | - | - | - | - | ||||||||||||||||||||||
Other income, net | 290 | 15 | 1,508 | 46 | 24 | 25 | 1 | 1,314 | |||||||||||||||||||||||||
Net loss | $ | (9,957 | ) | $ | (11,204 | ) | $ | (13,799 | ) | $ | (19,019 | ) | $ | (16,061 | ) | $ | (17,039 | ) | $ | (20,933 | ) | $ | (15,820 | ) | |||||||||
Net loss per share: | |||||||||||||||||||||||||||||||||
Basic | $ | (0.12 | ) | $ | (0.13 | ) | $ | (0.17 | ) | $ | (0.26 | ) | $ | (0.23 | ) | $ | (0.24 | ) | $ | (0.30 | ) | $ | (0.23 | ) | |||||||||
Diluted | $ | (0.12 | ) | $ | (0.13 | ) | $ | (0.17 | ) | $ | (0.26 | ) | $ | (0.23 | ) | $ | (0.24 | ) | $ | (0.30 | ) | $ | (0.23 | ) |
SCHEDULE_IIVALUATION_AND_QUALI
SCHEDULE II--VALUATION AND QUALIFYING ACCOUNTS | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||
SCHEDULE II--VALUATION AND QUALIFYING ACCOUNTS [Abstract] | ' | ||||||||||||||||||||
SCHEDULE II--VALUATION AND QUALIFYING ACCOUNTS | ' | ||||||||||||||||||||
SCHEDULE II--VALUATION AND QUALIFYING ACCOUNTS | |||||||||||||||||||||
Description | Balance | Additions | Deductions | Balance | |||||||||||||||||
(Dollars in Thousands) | at | charged to | at end of | ||||||||||||||||||
beginning | costs and | period | |||||||||||||||||||
of period | expenses | ||||||||||||||||||||
Year ended December 31, 2013: | |||||||||||||||||||||
Deducted from asset account: | |||||||||||||||||||||
Allowance for doubtful accounts | $ | 172 | $ | - | - | (1 | ) | $ | 172 | ||||||||||||
Reserve for excess and obsolete inventory | 5,887 | 122 | (2,031 | ) | (2 | ) | 3,978 | ||||||||||||||
Year ended December 31, 2012: | |||||||||||||||||||||
Deducted from asset account: | |||||||||||||||||||||
Allowance for doubtful accounts | $ | 172 | $ | - | - | (1 | ) | $ | 172 | ||||||||||||
Reserve for excess and obsolete inventory | 5,559 | 1,317 | (989 | ) | (2 | ) | 5,887 | ||||||||||||||
Year ended December 31, 2011: | |||||||||||||||||||||
Deducted from asset account: | |||||||||||||||||||||
Allowance for doubtful accounts | $ | 739 | $ | - | (567 | ) | (1 | ) | $ | 172 | |||||||||||
Reserve for excess and obsolete inventory | 8,948 | 137 | (3,526 | ) | (2 | ) | 5,559 | ||||||||||||||
(1) Uncollectible accounts written-off to the allowance account. | |||||||||||||||||||||
(2) Inventory write-offs to the reserve account. |
SUMMARY_OF_SIGNIFICANT_ACCOUNT1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | ' | ||||||||||||||||||||||||
NATURE OF OPERATIONS AND BASIS OF PRESENTATION | ' | ||||||||||||||||||||||||
NATURE OF OPERATIONS AND BASIS OF PRESENTATION | |||||||||||||||||||||||||
ANADIGICS, Inc. (“the Company”) is a global leader in the design and manufacture of radio frequency semiconductor solutions for cellular, WiFi, and wireless infrastructure and CATV applications. The Company’s product portfolio includes power amplifiers, FEICs, FEMs, and line amplifiers. The Company’s cellular products enable mobile handsets, smartphones, tablets, notebooks, datacards, automotive, M2M, and industrial devices to access 3G and 4G wireless networks utilizing international standards, such as LTE, HSPA, WCDMA, EVDO, CDMA and WiMAX. The Company’s WiFi products enable wireless LAN connectivity for mobile, multimedia and infrastructure devices, such as smartphones, tablets, notebooks, televisions, set-top boxes, modems, routers, and access points. Our solutions are optimized for the latest WiFi standards, including 802.11ac and 802.11n. The Company’s infrastructure solutions include both wireless infrastructure and CATV products. The Company’s wireless infrastructure power amplifiers enable 3G and 4G small-cell base stations, while its CATV products provide the critical link in CATV network infrastructure devices. The Company believes its solutions are well positioned to address these market dynamics and will enable it to outpace the overall end product unit growth in the cellular, WiFi, wireless infrastructure and CATV markets. | |||||||||||||||||||||||||
The Company designs, develops and manufactures RFICs primarily using GaAs compound semiconductor substrates with various process technologies, MESFET, pHEMT, and HBT. The Company’s patented technology, which utilizes InGaP-PlusTM, combines InGaP HBT and pHEMT processes on a single substrate, enabling it to integrate the PA function and the RF active switch function on the same die. The Company fabricates substantially all of its ICs in its six-inch diameter GaAs wafer fabrication facility. | |||||||||||||||||||||||||
The consolidated financial statements include the accounts of ANADIGICS, Inc. and its wholly owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. | |||||||||||||||||||||||||
The Company has evaluated subsequent events and determined that, other than the workforce reduction disclosed in Note 2 and subsequent sale of a former-auction rate security disclosed in Note 4, there were no subsequent events to recognize or disclose in these consolidated financial statements. | |||||||||||||||||||||||||
USE OF ESTIMATES | ' | ||||||||||||||||||||||||
USE OF ESTIMATES | |||||||||||||||||||||||||
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and the accompanying notes. Actual results could differ from those estimates. Significant estimates that affect the financial statements include, but are not limited to: allowance for doubtful accounts, recoverability and valuation of inventories, warranty reserve, valuation of stock-based compensation, reserves for distributor arrangements and returns, valuation of certain marketable securities, useful lives and amortization periods and recoverability of long-lived assets. | |||||||||||||||||||||||||
CONCENTRATION OF CREDIT RISK | ' | ||||||||||||||||||||||||
CONCENTRATION OF CREDIT RISK | |||||||||||||||||||||||||
The Company grants trade credit to its customers, who are primarily foreign manufacturers of wireless communication devices, cable and broadcast television receivers and fiber optic communication devices. The Company performs periodic credit evaluations of its customers and generally does not require collateral. Sales and accounts receivable from customers are denominated in U.S. dollars. The Company has not experienced significant losses related to receivables from these individual customers. | |||||||||||||||||||||||||
Net sales to individual customers and their affiliates who accounted for 10% or more of the Company’s total net sales and corresponding end application information are as follows: | |||||||||||||||||||||||||
YEAR ENDED DECEMBER 31 | |||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||
Customer (primary application) | $ | % | $ | % | $ | % | |||||||||||||||||||
Samsung Electronics (Cellular / WiFi) | 54,187 | 40 | % | 34,372 | 31 | % | 29,326 | 19 | % | ||||||||||||||||
Huawei Technologies (Cellular) | 15,731 | 12 | % | 15,169 | 14 | % | <10 | % | <10 | % | |||||||||||||||
Murata (WiFi) | 14,274 | 11 | % | <10 | % | <10 | % | <10 | % | <10 | % | ||||||||||||||
ZTE Corporation (Cellular) | <10 | % | <10 | % | 12,818 | 11 | % | 20,416 | 13 | % | |||||||||||||||
Research In Motion Limited (Cellular) | <10 | % | <10 | % | <10 | % | <10 | % | 33,704 | 22 | % | ||||||||||||||
Accounts receivable at December 31, 2013 and 2012 from the greater than 10% customers accounted for 58% and 69% of total accounts receivable, respectively. | |||||||||||||||||||||||||
REVENUE RECOGNITION | ' | ||||||||||||||||||||||||
REVENUE RECOGNITION | |||||||||||||||||||||||||
Revenue from product sales is recognized when title to the products is transferred to the customer, which occurs upon shipment or delivery, depending upon the terms of the sales order. The Company sells to certain distributors who are granted limited contractual rights of return and exchange and certain pre-negotiated individual product-customer price protection. Revenue from sales of products to distributors is recognized, net of allowances, upon shipment of the products to the distributors. At the time of shipment, title transfers to the distributors and payment from the distributors is due on our standard commercial terms; payment terms are not contingent upon resale of the products. Revenue is appropriately reduced for the portion of shipments subject to return, exchange or price protection. Allowances for the distributors are recorded upon shipment and calculated based on the distributors’ indicated intent, historical data, current economic conditions and contractual terms. The Company believes it can reasonably and reliably estimate allowances for credits to distributors in a timely manner. The Company charges customers for the costs of certain contractually-committed inventories that remain at the end of a product's life. Such amounts are recognized as cancellation revenue when cash is received. The value of the inventory related to cancellation revenue may, in some instances, have been reserved during prior periods in accordance with the Company’s inventory obsolescence policy. The Company maintains an allowance for doubtful accounts for estimated losses resulting from customers' failure to make payments. | |||||||||||||||||||||||||
ALLOWANCE FOR DOUBTFUL ACCOUNTS | ' | ||||||||||||||||||||||||
ALLOWANCE FOR DOUBTFUL ACCOUNTS | |||||||||||||||||||||||||
The Company establishes an allowance for doubtful accounts for estimated losses resulting from customers' failure to make payments, based upon historical experience. | |||||||||||||||||||||||||
WARRANTY COSTS | ' | ||||||||||||||||||||||||
WARRANTY COSTS | |||||||||||||||||||||||||
The Company provides, by a current charge to income, an amount it estimates, by examining historical returns and other information it deems critical, will be needed to cover future warranty obligations for products sold during the year. The liability for warranty costs is included in Accrued liabilities in the consolidated balance sheets. | |||||||||||||||||||||||||
PLANT AND EQUIPMENT | ' | ||||||||||||||||||||||||
PLANT AND EQUIPMENT | |||||||||||||||||||||||||
Plant and equipment are stated at cost. Depreciation of plant, furniture and equipment has been provided on the straight-line method over 3-7 years. Leasehold improvements are amortized and included in depreciation over the useful life of the leasehold or the life of the lease, whichever is shorter. | |||||||||||||||||||||||||
IMPAIRMENT OF LONG-LIVED ASSETS | ' | ||||||||||||||||||||||||
IMPAIRMENT OF LONG-LIVED ASSETS | |||||||||||||||||||||||||
Long-lived assets used in operations are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets might not be recoverable. For long-lived assets to be held and used, the Company recognizes an impairment loss if its carrying amount is not recoverable through its undiscounted cash flows and measures the impairment loss based on the difference between the carrying amount and fair value. Long-lived assets held for sale are reported at the lower of cost or fair value less costs to sell. | |||||||||||||||||||||||||
INCOME TAXES | ' | ||||||||||||||||||||||||
INCOME TAXES | |||||||||||||||||||||||||
Deferred income taxes reflect the net effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the income tax basis of such assets and liabilities. The Company maintains a full valuation allowance on its deferred tax assets. Accordingly, the Company has not recorded a benefit or provision for income taxes. The Company recognizes interest and penalties related to the underpayment of income taxes in income tax expense. No unrecognized tax benefits, interest or penalties were accrued at December 31, 2013 and 2012. The Company’s U.S. federal net operating losses have occurred since 1998 and as such, tax years subject to potential tax examination could apply from that date because carrying-back net operating loss opens the relevant year to audit. | |||||||||||||||||||||||||
RESEARCH AND DEVELOPMENT COSTS | ' | ||||||||||||||||||||||||
RESEARCH AND DEVELOPMENT COSTS | |||||||||||||||||||||||||
The Company charges all research and development costs associated with the development of new products to expense when incurred. | |||||||||||||||||||||||||
CASH EQUIVALENTS | ' | ||||||||||||||||||||||||
CASH EQUIVALENTS | |||||||||||||||||||||||||
The Company considers all highly liquid marketable securities with a maturity of three months or less when purchased to be cash equivalents. | |||||||||||||||||||||||||
MARKETABLE SECURITIES | ' | ||||||||||||||||||||||||
MARKETABLE SECURITIES | |||||||||||||||||||||||||
Available for sale securities are stated at fair value, as determined by quoted market prices or as needed, independent valuation models, with unrealized gains and losses reported in other accumulated comprehensive income or loss. Unrealized losses are reviewed and those considered other than temporary are recorded as a charge to other income (expense). Subsequent gains or losses upon redemption or sale of these securities in excess of, or below, their adjusted cost basis are also recorded as other income (expense). The Company considers it more likely than not that it will sell certain auction rate securities prior to a full recovery in valuation. The cost of securities sold is based upon the specific identification method. The amortized cost of securities is adjusted for amortization of premium and accretion of market discounts over the securities’ effective life or maturity and recorded in interest income. See Note 4 for a summary of marketable securities. | |||||||||||||||||||||||||
INVENTORY | ' | ||||||||||||||||||||||||
INVENTORY | |||||||||||||||||||||||||
Inventories are valued at the lower of cost or market ("LCM"), using the first-in, first-out method. The Company capitalizes production overhead costs to inventory on the basis of normal capacity of its production facility and in periods of abnormally low utilization charges the related expenses as a period cost in the statement of operations. In addition to LCM limitations, the Company reserves against inventory items for estimated obsolescence or unmarketable inventory. The reserve for excess and obsolete inventory is primarily based upon forecasted short-term demand for the product. Once established, these write-downs are considered permanent adjustments to the cost basis of the excess inventory. If actual demand and market conditions are less favorable than those projected by management, additional inventory write-downs may be required. In the event the Company sells inventory that had been covered by a specific inventory reserve, the sale is recorded at the actual selling price and the related cost of goods sold at the full inventory cost, net of the reserve. | |||||||||||||||||||||||||
DEFERRED RENT | ' | ||||||||||||||||||||||||
DEFERRED RENT | |||||||||||||||||||||||||
Aggregate rental expense is recognized on a straight-line basis over the lease terms of operating leases that contain predetermined increases in rentals payable during the lease term. | |||||||||||||||||||||||||
FOREIGN CURRENCY TRANSLATION | ' | ||||||||||||||||||||||||
FOREIGN CURRENCY TRANSLATION | |||||||||||||||||||||||||
The financial statements of subsidiaries outside of the United States are measured using the local currency as the functional currency. Assets and liabilities of these subsidiaries are translated at the rates of exchange at the balance sheet dates. The resultant translation adjustments are included in other accumulated comprehensive income or loss. Income and expense items are translated at the average monthly rates of exchange. Gains and losses from foreign currency transactions of these subsidiaries are included in the determination of net income or loss. | |||||||||||||||||||||||||
EARNINGS PER SHARE | ' | ||||||||||||||||||||||||
EARNINGS PER SHARE | |||||||||||||||||||||||||
Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised resulting in the issuance of common stock of the Company. Any dilution arising from the Company's outstanding stock awards will not be included where their effect is anti-dilutive. | |||||||||||||||||||||||||
FAIR VALUE OF FINANCIAL INSTRUMENTS | ' | ||||||||||||||||||||||||
FAIR VALUE OF FINANCIAL INSTRUMENTS | |||||||||||||||||||||||||
The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The fair value of each of the following instruments approximates their carrying value because of the short maturity of these instruments: cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities. See Note 4 for additional fair value disclosures. | |||||||||||||||||||||||||
STOCK-BASED COMPENSATION | ' | ||||||||||||||||||||||||
STOCK-BASED COMPENSATION | |||||||||||||||||||||||||
The Company has various stock-based compensation plans for employees and directors, which are described more fully in Note 10. The Company records stock compensation expense for all stock-based payment awards made to its employees and directors. Stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period which in most cases is the vesting period. | |||||||||||||||||||||||||
RECLASSIFICATIONS | ' | ||||||||||||||||||||||||
RECLASSIFICATIONS | |||||||||||||||||||||||||
Certain prior period amounts have been reclassified to conform to the current presentation. | |||||||||||||||||||||||||
IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS | ' | ||||||||||||||||||||||||
IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS | |||||||||||||||||||||||||
Changes to accounting principles generally accepted in the United States of America (“U.S. GAAP”) are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates to the FASB’s Accounting Standards Codification. | |||||||||||||||||||||||||
In February 2013, the FASB amended its disclosure requirements for those amounts reclassified out of accumulated other comprehensive income. Entities are required to separately disclose each component of other comprehensive income, current period reclassifications out of accumulated other comprehensive income, and other amounts of current-period other comprehensive income. Additional information is required about the effects on net income of significant amounts reclassified out of each component of accumulated other comprehensive income. These additional disclosure requirements are required for reporting periods beginning after December 31, 2012. Adoption of this guidance during the first quarter of 2013 resulted in the Company making the required disclosures in the Notes to its consolidated financial statements. | |||||||||||||||||||||||||
In December 2011, the FASB and International Accounting Standards Board (“IASB”) issued joint requirements related to balance sheet disclosures related to offsetting assets and liabilities. Entities are required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. This scope includes derivatives, sale and repurchase agreements and reverse sale and repurchase agreements, and securities borrowing and securities lending arrangements. The objective of this disclosure is to facilitate comparison between those entities that prepare their financial statements on the basis of U.S. GAAP and those entities that prepare their financial statements on the basis of International Financial Reporting Standards (“IFRS”). Disclosures are required to be retrospective for all comparative periods presented. Adoption of this standard was required in the first quarter of 2013 and did not have a material impact on the Company’s consolidated financial statements. |
SUMMARY_OF_SIGNIFICANT_ACCOUNT2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | ' | ||||||||||||||||||||||||
Net sales and corresponding end application information | ' | ||||||||||||||||||||||||
Net sales to individual customers and their affiliates who accounted for 10% or more of the Company’s total net sales and corresponding end application information are as follows: | |||||||||||||||||||||||||
YEAR ENDED DECEMBER 31 | |||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||
Customer (primary application) | $ | % | $ | % | $ | % | |||||||||||||||||||
Samsung Electronics (Cellular / WiFi) | 54,187 | 40 | % | 34,372 | 31 | % | 29,326 | 19 | % | ||||||||||||||||
Huawei Technologies (Cellular) | 15,731 | 12 | % | 15,169 | 14 | % | <10 | % | <10 | % | |||||||||||||||
Murata (WiFi) | 14,274 | 11 | % | <10 | % | <10 | % | <10 | % | <10 | % | ||||||||||||||
ZTE Corporation (Cellular) | <10 | % | <10 | % | 12,818 | 11 | % | 20,416 | 13 | % | |||||||||||||||
Research In Motion Limited (Cellular) | <10 | % | <10 | % | <10 | % | <10 | % | 33,704 | 22 | % |
RESTRUCTURING_MANAGEMENT_SEPAR1
RESTRUCTURING, MANAGEMENT SEPARATION CHARGES, AND SUBSEQUENT EVENT (Tables) | 12 Months Ended | ||||
Dec. 31, 2013 | |||||
RESTRUCTURING, MANAGEMENT SEPARATION CHARGES, AND SUBSEQUENT EVENT | ' | ||||
Activity and liability balances related to the restructurings | ' | ||||
Activity and liability balances related to the restructurings were as follows: | |||||
Accrued | |||||
Restructuring Costs | |||||
December 31, 2011 balance | $ | - | |||
Restructuring expense | 2,338 | ||||
Payments | (1,943 | ) | |||
December 31, 2012 balance | $ | 395 | |||
Restructuring expense | 1,915 | ||||
Payments | (2,065 | ) | |||
December 31, 2013 balance | $ | 245 |
SEGMENTS_Tables
SEGMENTS (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
SEGMENTS [Abstract] | ' | ||||||||||||
Revenues based upon end application of product | ' | ||||||||||||
The Company classifies its revenues based upon the end application of the product in which its ICs are used. Net sales by end application are regularly reviewed by the chief operating decision maker and are as follows: | |||||||||||||
Year Ended December 31, | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Cellular | $ | 74,153 | $ | 83,809 | $ | 119,472 | |||||||
Infrastructure | 19,578 | 23,690 | 28,162 | ||||||||||
WiFi | 40,511 | 5,144 | 5,193 | ||||||||||
Total | $ | 134,242 | $ | 112,643 | $ | 152,827 | |||||||
Schedule of revenue from external customers | ' | ||||||||||||
The Company sells to five geographic regions: Asia, Europe, Latin America, USA and Other. The geographic region is determined by the destination of the shipped product. Net sales to each of the five geographic regions are as follows: | |||||||||||||
Year Ended December 31, | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Asia | $ | 125,027 | $ | 92,652 | $ | 102,437 | |||||||
Europe | 1,680 | 3,881 | 14,146 | ||||||||||
Latin America | 5,669 | 9,101 | 29,027 | ||||||||||
USA | 1,865 | 6,601 | 6,934 | ||||||||||
Other | 1 | 408 | 283 | ||||||||||
Total | $ | 134,242 | $ | 112,643 | $ | 152,827 |
FAIR_VALUE_AND_MARKETABLE_SECU1
FAIR VALUE AND MARKETABLE SECURITIES (Tables) | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||
FAIR VALUE AND MARKETABLE SECURITIES [Abstract] | ' | ||||||||||||||||||||
Fair value of available-for-sale securities | ' | ||||||||||||||||||||
The Company endeavors to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following table presents a summary of fair value information for available-for-sale securities: | |||||||||||||||||||||
Fair Value Measurements at Reporting Date Using | |||||||||||||||||||||
Security Type | Amortized | Fair Value | Quoted Prices in | Significant | Significant | ||||||||||||||||
Cost Basis | Active Markets | Other | Unobservable | ||||||||||||||||||
-1 | for Identical | Observable | Inputs | ||||||||||||||||||
Assets | Inputs | (Level 3) | |||||||||||||||||||
(Level 1) | (Level 2) | ||||||||||||||||||||
Fixed Income Securities (2) | $ | 10,235 | $ | 10,240 | $ | - | $ | 10,240 | $ | - | |||||||||||
U.S. Government Agency debt securities (2) | 7,508 | 7,510 | 7,510 | - | - | ||||||||||||||||
Former-auction corporate debt security (3) | 1,740 | 3,078 | - | 3,078 | - | ||||||||||||||||
Auction Rate Securities | |||||||||||||||||||||
Preferred Equity | 2,404 | 4,081 | - | 2,513 | 1,568 | ||||||||||||||||
State and Municipal Debt (3) | 1,394 | 1,652 | - | 1,652 | - | ||||||||||||||||
Total at December 31, 2012 | $ | 23,281 | $ | 26,561 | $ | 7,510 | $ | 17,483 | $ | 1,568 | |||||||||||
Former-auction corporate debt security (3) | $ | 1,800 | $ | 2,997 | $ | - | $ | 2,997 | $ | - | |||||||||||
Auction Rate Security - Preferred Equity | - | 450 | - | - | 450 | ||||||||||||||||
Total at December 31, 2013 | $ | 1,800 | $ | 3,447 | $ | - | $ | 2,997 | $ | 450 | |||||||||||
(1) Difference between amortized cost basis and fair value represents gross unrealized gain or loss. | |||||||||||||||||||||
(2) Available for sale debt securities with contractual maturities of one year or less. | |||||||||||||||||||||
(3) Available for sale debt securities with contractual maturities in excess of 10 years. | |||||||||||||||||||||
Reconciliation of the beginning and ending balances for each type of security valued using a Level 3 valuation | ' | ||||||||||||||||||||
The table below provides a reconciliation of the beginning and ending balances for each type of security valued using a Level 3 valuation. | |||||||||||||||||||||
($ in 000’s) | Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||
Years ended December 31, 2012 and 2013 | |||||||||||||||||||||
Corporate | Preferred Equity Security | Total | |||||||||||||||||||
Debt | Monoline insurers (b) | ||||||||||||||||||||
Security (a) | |||||||||||||||||||||
Balance at December 31, 2011 | $ | 1,215 | $ | 628 | $ | 1,843 | |||||||||||||||
Transfers out of Level 3 | - | - | - | ||||||||||||||||||
Total gains or losses realized/unrealized | |||||||||||||||||||||
Included in net loss | 1,250 | - | 1,250 | ||||||||||||||||||
Included in other comprehensive income | (452 | ) | 940 | 488 | |||||||||||||||||
Redemptions | (2,013 | ) | - | (2,013 | ) | ||||||||||||||||
Ending Balance December 31, 2012 | $ | - | $ | 1,568 | $ | 1,568 | |||||||||||||||
Transfers out of Level 3 | - | - | - | ||||||||||||||||||
Total gains or losses realized/unrealized | |||||||||||||||||||||
Included in net loss | - | 872 | 872 | ||||||||||||||||||
Included in other comprehensive income | - | 10 | 10 | ||||||||||||||||||
Redemptions | - | (2,000 | ) | (2,000 | ) | ||||||||||||||||
Ending Balance December 31, 2013 | $ | - | $ | 450 | $ | 450 | |||||||||||||||
Amount of total gains or losses for the period included in earnings(loss) attributable to the change in unrealized gains or losses relating to Level 3 assets still held at the reporting date | $ | - | $ | - | $ | - | |||||||||||||||
Level 3 security held at December 31, 2013: | |||||||||||||||||||||
Face value | - | $ | 1,125 | $ | 1,125 | ||||||||||||||||
Financial ratings | - | NR | |||||||||||||||||||
Weighted average interest rate (*) | - | 0 | % | 0 | % | ||||||||||||||||
Maturity date | - | N/ | A | ||||||||||||||||||
(a) Security issued by a publicly-held insurance company trust, which holds investments in U.S. Government obligations, highly rated commercial paper and money market funds and other investments approved by two credit rating agencies. The $2,500 face value security was redeemed by the issuer at a discount in the first quarter of 2012 for $2,013, resulting in a gain over its amortized cost basis of $1,250. | |||||||||||||||||||||
(b) Preferred securities issued by subsidiaries of two publicly-held debt default insurers. During the second quarter of 2013, one of these securities redeemed at $2,000 par, resulting in an $872 realized gain recorded to Other income, net. |
INVENTORIES_Tables
INVENTORIES (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
INVENTORIES [Abstract] | ' | ||||||||
Inventories | ' | ||||||||
Inventories consist of the following: | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Raw materials | $ | 7,323 | $ | 5,108 | |||||
Work in progress | 8,424 | 9,781 | |||||||
Finished goods | 5,367 | 3,951 | |||||||
Total | $ | 21,114 | $ | 18,840 |
ACCRUED_LIABILITIES_Tables
ACCRUED LIABILITIES (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
ACCRUED LIABILITIES [Abstract] | ' | ||||||||||||
Accrued liabilities | ' | ||||||||||||
Accrued liabilities consist of the following: | |||||||||||||
December 31, | |||||||||||||
2013 | 2012 | ||||||||||||
Accrued compensation | $ | 1,844 | $ | 1,945 | |||||||||
Warranty reserve | 383 | 770 | |||||||||||
Other | 2,153 | 1,630 | |||||||||||
$ | 4,380 | $ | 4,345 | ||||||||||
Product warranty reserve | ' | ||||||||||||
Changes in the Company’s product warranty reserve are as follows: | |||||||||||||
Year ended December 31 | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Beginning balance | $ | 770 | $ | 430 | $ | 571 | |||||||
Additions charged to costs and expenses | 554 | 1,507 | 871 | ||||||||||
Claims processed | (941 | ) | (1,167 | ) | (1,012 | ) | |||||||
Ending balance | $ | 383 | $ | 770 | $ | 430 |
COMMITMENTS_AND_CONTIGENCIES_T
COMMITMENTS AND CONTIGENCIES (Tables) | 12 Months Ended | ||||
Dec. 31, 2013 | |||||
COMMITMENTS AND CONTINGENCIES [Abstract] | ' | ||||
Future minimum rental payments for operating leases | ' | ||||
The Company leases manufacturing, warehousing and office space under noncancelable operating leases that expire through 2016. Rent expense was $2,350, $2,567, $2,617, in 2013, 2012 and 2011, respectively. At December 31, 2013 and 2012, there were no capital lease obligations outstanding. The future minimum lease payments under the noncancelable operating leases, excluding deferred rent adjustments. are as follows: | |||||
YEAR | Operating | ||||
Leases | |||||
2014 | $ | 2,783 | |||
2015 | 2,630 | ||||
2016 | 2,408 | ||||
2017 | 210 | ||||
2018 | 131 | ||||
Thereafter | 11 | ||||
Total minimum lease payments | $ | 8,173 |
INCOME_TAXES_Tables
INCOME TAXES (Tables) | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
INCOME TAXES [Abstract] | ' | ||||||||||||||||||||||||
Significant components of the Company's net deferred taxes | ' | ||||||||||||||||||||||||
Significant components of the Company’s net deferred taxes as of December 31, 2013 and 2012 are as follows: | |||||||||||||||||||||||||
December 31, | |||||||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||||||
Deferred tax balances | |||||||||||||||||||||||||
Accruals/reserves | $ | 7,652 | $ | 9,091 | |||||||||||||||||||||
Net operating loss carryforwards | 210,894 | 181,815 | |||||||||||||||||||||||
Research and experimentation credits | 14,414 | 14,086 | |||||||||||||||||||||||
Deferred rent expense | 614 | 772 | |||||||||||||||||||||||
Difference in basis of plant and equipment | 9,791 | 9,483 | |||||||||||||||||||||||
Valuation allowance | (243,365 | ) | (215,247 | ) | |||||||||||||||||||||
Net deferred tax assets | - | - | |||||||||||||||||||||||
Reconciliation of income tax expense | ' | ||||||||||||||||||||||||
The reconciliation of income tax expense computed at the U.S. federal statutory rate to the benefit from income taxes is as follows: | |||||||||||||||||||||||||
Year Ended December 31, | |||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||
Tax at U.S. statutory rate | $ | (18,893 | ) | (35.0 | )% | $ | (24,448 | ) | (35.0 | )% | $ | (17,263 | ) | (35.0 | )% | ||||||||||
Effect of permanent items | 6 | - | 163 | 0.2 | (2 | ) | - | ||||||||||||||||||
State and foreign tax (benefit), net of federal tax effect | (1,754 | ) | (3.2 | ) | (2,255 | ) | (3.2 | ) | (1,603 | ) | (3.3 | ) | |||||||||||||
Research and experimentation tax credits, net | (328 | ) | (0.6 | ) | (33 | ) | (0.1 | ) | (68 | ) | (0.1 | ) | |||||||||||||
Valuation allowance, net | 28,118 | 52.1 | 23,802 | 34.1 | 16,181 | 32.8 | |||||||||||||||||||
Worthless stock deduction | (4,997 | ) | (9.3 | ) | - | - | - | - | |||||||||||||||||
Other | (2,152 | ) | (4.0 | ) | 2,771 | 4 | 2,755 | 5.6 | |||||||||||||||||
(Benefit from) provision for income taxes | $ | - | - | % | $ | - | - | % | $ | - | - | % |
EMPLOYEE_BENEFIT_PLANS_Tables
EMPLOYEE BENEFIT PLANS (Tables) | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
EMPLOYEE BENEFIT PLANS [Abstract] | ' | ||||||||||||||||||||||||
Summary of stock-based compensation by source | ' | ||||||||||||||||||||||||
The table below summarizes stock-based compensation by source and by financial statement line item: | |||||||||||||||||||||||||
For years ended December 31, | |||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||
Amortization of restricted stock awards | $ | 6,239 | $ | 4,813 | $ | 9,308 | |||||||||||||||||||
Amortization of ESP Plan | 149 | 314 | 307 | ||||||||||||||||||||||
Amortization of stock option awards | 128 | 670 | 1,899 | ||||||||||||||||||||||
Total stock-based compensation | $ | 6,516 | $ | 5,797 | $ | 11,514 | |||||||||||||||||||
By Financial Statement line item | |||||||||||||||||||||||||
Cost of sales | $ | 1,041 | $ | 888 | $ | 1,798 | |||||||||||||||||||
Research and development expenses | 2,118 | 1,626 | 2,981 | ||||||||||||||||||||||
Selling and administrative expenses | 3,428 | 3,218 | 6,815 | ||||||||||||||||||||||
Restructuring charges | (71 | ) | 65 | (80 | ) | ||||||||||||||||||||
Restricted stock and stock option awards activity | ' | ||||||||||||||||||||||||
Grant, vest and forfeit activity and related weighted average (WA) price per share for restricted stock and for stock options during the period from January 1, 2011 to December 31, 2013 is presented in tabular form below: | |||||||||||||||||||||||||
Restricted Stock | Restricted Stock | Stock | |||||||||||||||||||||||
Shares | Units | Options | |||||||||||||||||||||||
Shares | WA price per share | Units | WA price per unit | Issuable upon exercise | WA exercise price | ||||||||||||||||||||
Shares outstanding at December 31, 2010 | 180 | $ | 8.39 | 1,460 | $ | 4.49 | 4,143 | $ | 4.96 | ||||||||||||||||
Granted (1) | - | - | 2,573 | 5.91 | 1,065 | 3.29 | |||||||||||||||||||
Shares vested/options exercised | (179 | ) | 8.38 | (1,654 | ) | 5.08 | (442 | ) | 2.12 | ||||||||||||||||
Forfeited/expired (2) | (1 | ) | 9.72 | (409 | ) | 6.03 | (491 | ) | 9.37 | ||||||||||||||||
Balance at December 31, 2011 | - | - | 1,970 | $ | 5.52 | 4,275 | $ | 4.32 | |||||||||||||||||
Granted | - | - | 661 | 2.32 | 13 | 1.97 | |||||||||||||||||||
Shares vested/options exercised | - | - | (1,102 | ) | 4.69 | (950 | ) | 2.02 | |||||||||||||||||
Forfeited/expired (2) | - | - | (99 | ) | 6.21 | (843 | ) | 5.21 | |||||||||||||||||
Balance at December 31, 2012 | - | - | 1,430 | $ | 4.63 | 2,495 | $ | 4.89 | |||||||||||||||||
Granted (1) | - | - | 3,509 | 2.11 | 13 | 2.26 | |||||||||||||||||||
Shares vested/options exercised | - | - | (1,539 | ) | 3.34 | (69 | ) | 1.93 | |||||||||||||||||
Forfeited/expired (2,3) | - | - | (528 | ) | 2.5 | (480 | ) | 3.99 | |||||||||||||||||
Balance at December 31, 2013 | - | - | 2,872 | $ | 2.63 | 1,959 | $ | 5.2 | |||||||||||||||||
-1 | Year 2011 stock options granted include 417 performance-based stock option shares; | ||||||||||||||||||||||||
Year 2013 restricted stock units granted include 560 performance-based restricted stock units. | |||||||||||||||||||||||||
-2 | Years 2011, 2012, and 2013 stock options forfeited include 167, 83 and 42 performance-based option shares, respectively; Year 2013 restricted stock units forfeited include 384 performance-based units. | ||||||||||||||||||||||||
-3 | In the second quarter of 2013, 125 time-based and 83 (125 at maximum performance achievement) performance-based stock options were rescinded with the consent of and without payment to the CEO due to the fact that the original grants with respect to which these options were a part of exceeded the sub-limits of the applicable plan by the number of shares as to which the options were rescinded. | ||||||||||||||||||||||||
Stock-based compensation, weighted average information | ' | ||||||||||||||||||||||||
The total fair value of restricted stock vested during the years ended December 31, 2013, 2012 and 2011 were $3,052, $2,208 and $6,942, respectively. The intrinsic value of exercised options during the years ended December 31, 2013, 2012 and 2011 were $14, $512 and $787, respectively. | |||||||||||||||||||||||||
Weighted average information as of | |||||||||||||||||||||||||
31-Dec-13 | |||||||||||||||||||||||||
Options currently exercisable | |||||||||||||||||||||||||
Shares issuable upon exercise | 1,840 | ||||||||||||||||||||||||
Weighted average exercise price | $ | 5.33 | |||||||||||||||||||||||
Weighted average remaining contractual term | 3.0 years | ||||||||||||||||||||||||
Weighted average remaining contractual term for outstanding options | 3.3 years | ||||||||||||||||||||||||
Intrinsic value of exercisable options | $ | 1 | |||||||||||||||||||||||
Intrinsic value of outstanding options | $ | 2 | |||||||||||||||||||||||
Unrecognized stock-based compensation cost | |||||||||||||||||||||||||
Option plans | $ | 109 | |||||||||||||||||||||||
Restricted stock | $ | 3,304 | |||||||||||||||||||||||
Weighted average remaining vest period for option plans | 0.7 years | ||||||||||||||||||||||||
Weighted average remaining vest period for restricted stock | 1.3 years | ||||||||||||||||||||||||
Stock options outstanding by exercise price range | ' | ||||||||||||||||||||||||
Stock options outstanding at December 31, 2013 are summarized as follows: | |||||||||||||||||||||||||
Range of exercise prices | Outstanding | Weighted | Weighted | Exercisable at | Weighted | ||||||||||||||||||||
Options at | average | average | December 31, | average exercise | |||||||||||||||||||||
December 31, | remaining | exercise | 2013 | price | |||||||||||||||||||||
2013 | contractual life | price | |||||||||||||||||||||||
$ | 1.23 - $1.93 | 646 | 3.7 | $ | 1.93 | 641 | $ | 1.93 | |||||||||||||||||
$ | 2.00 - $3.24 | 322 | 7.3 | $ | 3.18 | 209 | $ | 3.19 | |||||||||||||||||
$ | 3.30 - $8.79 | 493 | 1 | $ | 6.56 | 492 | $ | 6.56 | |||||||||||||||||
$ | 8.84 - $18.98 | 498 | 2.4 | $ | 9.4 | 498 | $ | 9.4 | |||||||||||||||||
Weighted average assumptions and fair values for stock-based compensation grants | ' | ||||||||||||||||||||||||
The fair value of these equity awards was estimated at the date of grant using a Black-Scholes option pricing model. The weighted average assumptions and fair values for stock-based compensation grants used for the years ended December 31, 2013, 2012 and 2011 are summarized below (excludes the aforementioned performance-based option grants). | |||||||||||||||||||||||||
Year ended December 31, | |||||||||||||||||||||||||
2013 | 2012 | 2011 | |||||||||||||||||||||||
Stock option awards: | |||||||||||||||||||||||||
Risk-free interest rate | 0.8 | % | 1 | % | 2.2 | % | |||||||||||||||||||
Expected volatility | 72 | % | 70 | % | 65 | % | |||||||||||||||||||
Average expected term (in years) | 5 | 5 | 5 | ||||||||||||||||||||||
Expected dividend yield | 0 | % | 0 | % | 0 | % | |||||||||||||||||||
Weighted average fair value of options granted | $ | 1.36 | $ | 1.14 | $ | 1.85 | |||||||||||||||||||
ESP Plan: | |||||||||||||||||||||||||
Risk-free interest rate | 0.1 | % | 0.2 | % | 0.1 | % | |||||||||||||||||||
Expected volatility | 51 | % | 61 | % | 66 | % | |||||||||||||||||||
Average expected term | 1 | 1 | 1 | ||||||||||||||||||||||
Expected dividend yield | 0 | % | 0 | % | 0 | % | |||||||||||||||||||
Weighted average fair value of purchase option | $ | 0.55 | $ | 0.77 | $ | 0.8 |
LOSS_PER_SHARE_Tables
LOSS PER SHARE (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
LOSS PER SHARE [Abstract] | ' | ||||||||||||
Reconciliation of shares used to calculate basic and diluted loss per share | ' | ||||||||||||
The reconciliation of shares used to calculate basic and diluted loss per share consists of the following: | |||||||||||||
Year ended December 31, | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Weighted average common shares for basic loss per share | 80,991 | 70,721 | 67,771 | ||||||||||
Effect of dilutive securities: | |||||||||||||
Stock options (*) | - | - | - | ||||||||||
Unvested restricted stock (*) | - | - | - | ||||||||||
Adjusted weighted average shares for diluted loss per share | 80,991 | 70,721 | 67,771 | ||||||||||
* | Incremental shares from restricted stock and stock options are computed using the treasury stock method. | ||||||||||||
Anti-dilutive shares excluded from the calculation of basic earnings per share | ' | ||||||||||||
Dilution arising from the Company's outstanding stock options or unvested restricted stock was not included in the years ended December 31, 2013, 2012 and 2011 as their effect was anti-dilutive. Potential dilution arising from any of the remainder of the Company's outstanding stock options or unvested restricted stock is detailed below. Such potential dilution was excluded as their effect was anti-dilutive. | |||||||||||||
Year ended December 31, | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Stock options | 1,959 | 2,495 | 4,275 | ||||||||||
Unvested restricted stock | 2,872 | 1,430 | 1,970 |
OTHER_ACCUMULATED_COMPREHENSIV1
OTHER ACCUMULATED COMPREHENSIVE INCOME (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
OTHER ACCUMULATED COMPREHENSIVE INCOME [Abstract] | ' | ||||||||||||
Components of other accumulated comprehensive income | ' | ||||||||||||
The components of other accumulated comprehensive income are as follows: | |||||||||||||
Net Unrealized Gain (Loss) on Marketable Securities | Foreign Currency Translation | Total | |||||||||||
Balance at December 31, 2011 | $ | 1,255 | $ | (9 | ) | $ | 1,246 | ||||||
Other comprehensive income before reclassifications | 2,193 | 6 | 2,199 | ||||||||||
Amounts reclassified from accumulated other comprehensive income * | (1,393 | ) | - | (1,393 | ) | ||||||||
Net current period other comprehensive income | 800 | 6 | 806 | ||||||||||
Balance at December 31, 2012 | $ | 2,055 | $ | (3 | ) | $ | 2,052 | ||||||
Other comprehensive income before reclassifications | 1,371 | 3 | 1,374 | ||||||||||
Amounts reclassified from accumulated other comprehensive income * | (1,779 | ) | - | (1,779 | ) | ||||||||
Net current period other comprehensive income | (408 | ) | 3 | (405 | ) | ||||||||
Balance at December 31, 2013 | $ | 1,647 | $ | - | $ | 1,647 | |||||||
* Amounts reclassified are recorded within Other income, net in the Consolidated Statements of Operations |
QUARTERLY_FINANCIAL_DATA_UNAUD1
QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||||||||||
QUARTERLY FINANCIAL DATA (UNAUDITED) [Abstract] | ' | ||||||||||||||||||||||||||||||||
QUARTERLY FINANCIAL DATA (UNAUDITED) | ' | ||||||||||||||||||||||||||||||||
The following table sets forth certain unaudited results of operations for each quarter during 2013 and 2012. The unaudited information has been prepared on the same basis as the audited consolidated financial statements and includes all adjustments which management considers necessary for a fair presentation of the financial data shown. The operating results for any quarter are not necessarily indicative of the results to be attained for any future period. Basic and diluted loss per share are computed independently for each of the periods presented. Accordingly, the sum of the quarterly loss per share may not agree to the total for the year (in thousands, except for per share data). | |||||||||||||||||||||||||||||||||
Quarter Ended | |||||||||||||||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||||||||||||||
Dec. 31 | Sep. 28 | 29-Jun | Mar. 30 | Dec. 31 | Sep. 29 | 30-Jun | Mar. 31 | ||||||||||||||||||||||||||
Net sales | $ | 36,286 | $ | 37,011 | $ | 34,565 | $ | 26,380 | $ | 30,476 | $ | 28,642 | $ | 25,099 | $ | 28,426 | |||||||||||||||||
Cost of sales | 31,640 | 32,912 | 34,269 | 27,101 | 31,017 | 28,809 | 27,296 | 26,747 | |||||||||||||||||||||||||
Gross profit (loss) | 4,646 | 4,099 | 296 | (721 | ) | (541 | ) | (167 | ) | (2,197 | ) | 1,679 | |||||||||||||||||||||
Research and development expenses | 9,321 | 9,551 | 9,433 | 10,280 | 10,145 | 10,823 | 11,310 | 11,614 | |||||||||||||||||||||||||
Selling and administrative expense | 5,574 | 5,782 | 6,215 | 6,242 | 5,516 | 5,597 | 6,321 | 6,855 | |||||||||||||||||||||||||
Restructuring charges | - | - | - | 1,915 | - | 605 | 1,239 | 494 | |||||||||||||||||||||||||
Operating loss | (10,249 | ) | (11,234 | ) | (15,352 | ) | (19,158 | ) | (16,202 | ) | (17,192 | ) | (21,067 | ) | (17,284 | ) | |||||||||||||||||
Interest income | 33 | 46 | 65 | 93 | 117 | 128 | 133 | 150 | |||||||||||||||||||||||||
Interest expense | (31 | ) | (31 | ) | (20 | ) | - | - | - | - | - | ||||||||||||||||||||||
Other income, net | 290 | 15 | 1,508 | 46 | 24 | 25 | 1 | 1,314 | |||||||||||||||||||||||||
Net loss | $ | (9,957 | ) | $ | (11,204 | ) | $ | (13,799 | ) | $ | (19,019 | ) | $ | (16,061 | ) | $ | (17,039 | ) | $ | (20,933 | ) | $ | (15,820 | ) | |||||||||
Net loss per share: | |||||||||||||||||||||||||||||||||
Basic | $ | (0.12 | ) | $ | (0.13 | ) | $ | (0.17 | ) | $ | (0.26 | ) | $ | (0.23 | ) | $ | (0.24 | ) | $ | (0.30 | ) | $ | (0.23 | ) | |||||||||
Diluted | $ | (0.12 | ) | $ | (0.13 | ) | $ | (0.17 | ) | $ | (0.26 | ) | $ | (0.23 | ) | $ | (0.24 | ) | $ | (0.30 | ) | $ | (0.23 | ) | |||||||||
SUMMARY_OF_SIGNIFICANT_ACCOUNT3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | ' | ' | ' |
Percentage of revenue considered for major customer (in hundredths) | 10.00% | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' | ' |
Unrecognized tax benefits, interest or penalties accrued | $0 | $0 | ' |
Maximum maturity period considered for classification of cash equivalent | '3 months | ' | ' |
Minimum [Member] | ' | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' | ' |
Useful life | '3 years | ' | ' |
Maximum [Member] | ' | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' | ' |
Useful life | '7 years | ' | ' |
Accounts Receivable [Member] | Customer Concentration Risk [Member] | ' | ' | ' |
Net sales to major customer [Abstract] | ' | ' | ' |
Accounts receivable (in hundredths) | 58.00% | 69.00% | ' |
Samsung Electronics (Cellular / WiFi) [Member] | ' | ' | ' |
Net sales to major customer [Abstract] | ' | ' | ' |
Net sales, Amount | 54,187 | 34,372 | 29,326 |
Net sales (in hundredths) | 40.00% | 31.00% | 19.00% |
Huawei Technologies (Cellular) [Member] | ' | ' | ' |
Net sales to major customer [Abstract] | ' | ' | ' |
Net sales, Amount | 15,731 | 15,169 | ' |
Net sales (in hundredths) | 12.00% | 14.00% | ' |
Murata (WiFi) [Member] | ' | ' | ' |
Net sales to major customer [Abstract] | ' | ' | ' |
Net sales, Amount | 14,274 | ' | ' |
Net sales (in hundredths) | 11.00% | ' | ' |
ZTE Corporation (Wireless) [Member] | ' | ' | ' |
Net sales to major customer [Abstract] | ' | ' | ' |
Net sales, Amount | ' | 12,818 | 20,416 |
Net sales (in hundredths) | ' | 11.00% | 13.00% |
Research In Motion Limited (Cellular) [Member] | ' | ' | ' |
Net sales to major customer [Abstract] | ' | ' | ' |
Net sales, Amount | ' | ' | $33,704 |
Net sales (in hundredths) | ' | ' | 22.00% |
RESTRUCTURING_MANAGEMENT_SEPAR2
RESTRUCTURING, MANAGEMENT SEPARATION CHARGES, AND SUBSEQUENT EVENT (Details) (USD $) | 3 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | |||||||||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 28, 2013 | Jun. 29, 2013 | Mar. 30, 2013 | Dec. 31, 2012 | Sep. 29, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Feb. 28, 2014 | Feb. 28, 2014 | Apr. 02, 2011 | Apr. 02, 2011 | Dec. 31, 2011 | Apr. 02, 2011 | Dec. 31, 2011 | Apr. 02, 2011 |
Position | Position | Position | Subsequent Event [Member] | Workforce-related [Member] | Contract Termination [Member] | Contract Termination [Member] | Contract Termination [Member] | Contract Termination [Member] | Contract Termination [Member] | Contract Termination [Member] | |||||||||
Position | Subsequent Event [Member] | Research and development [Member] | Research and development [Member] | Selling and administrative expenses [Member] | Selling and administrative expenses [Member] | Selling and administrative expenses [Member] | Selling and administrative expenses [Member] | ||||||||||||
Accelerated Stock Based Compensation [Member] | Accelerated Stock Based Compensation [Member] | Accelerated Stock Based Compensation [Member] | |||||||||||||||||
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of positions eliminated | ' | ' | ' | ' | ' | ' | ' | ' | 25 | 40 | 40 | 40 | ' | ' | ' | ' | ' | ' | ' |
Severance and management separation charges | ' | ' | ' | ' | ' | ' | ' | ' | $1,915 | $2,338 | $1,047 | ' | $1,350 | $838 | $568 | $4,234 | $2,111 | $1,775 | $116 |
Activity and liability balances related to the restructuring [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Beginning Balance | ' | ' | ' | 395 | ' | ' | ' | 0 | 395 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Restructuring expense | 0 | 0 | 0 | 1,915 | 0 | 605 | 1,239 | 494 | 1,915 | 2,338 | 1,047 | ' | ' | ' | ' | ' | ' | ' | ' |
Payments | ' | ' | ' | ' | ' | ' | ' | ' | -2,065 | -1,943 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Ending Balance | $245 | ' | ' | ' | $395 | ' | ' | ' | $245 | $395 | $0 | ' | ' | ' | ' | ' | ' | ' | ' |
SEGMENTS_Details
SEGMENTS (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 28, 2013 | Jun. 29, 2013 | Mar. 30, 2013 | Dec. 31, 2012 | Sep. 29, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Segment | |||||||||||
Region | |||||||||||
SEGMENTS [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of reportable segments | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' |
Revenues based upon the end application of product [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | $36,286 | $37,011 | $34,565 | $26,380 | $30,476 | $28,642 | $25,099 | $28,426 | $134,242 | $112,643 | $152,827 |
Number of geographical regions | ' | ' | ' | ' | ' | ' | ' | ' | 5 | ' | ' |
Cellular [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenues based upon the end application of product [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 74,153 | 83,809 | 119,472 |
Infrastructure [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenues based upon the end application of product [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 19,578 | 23,690 | 28,162 |
WiFi [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenues based upon the end application of product [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | $40,511 | $5,144 | $5,193 |
SEGMENTS_Schedule_of_Revenue_f
SEGMENTS, Schedule of Revenue from External Customers (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 28, 2013 | Jun. 29, 2013 | Mar. 30, 2013 | Dec. 31, 2012 | Sep. 29, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Net sales to geographic regions [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | $36,286 | $37,011 | $34,565 | $26,380 | $30,476 | $28,642 | $25,099 | $28,426 | $134,242 | $112,643 | $152,827 |
Asia [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales to geographic regions [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 125,027 | 92,652 | 102,437 |
Europe [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales to geographic regions [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 1,680 | 3,881 | 14,146 |
Latin America [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales to geographic regions [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 5,669 | 9,101 | 29,027 |
USA [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales to geographic regions [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 1,865 | 6,601 | 6,934 |
Other [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales to geographic regions [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | $1 | $408 | $283 |
FAIR_VALUE_AND_MARKETABLE_SECU2
FAIR VALUE AND MARKETABLE SECURITIES (Details) (USD $) | 12 Months Ended | |||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Interest income recognized to accrete amortized cost basis of existing and former-auction debt securities | $93 | $118 | ||
Minimum [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale debt securities, contractual maturities | '10 years | ' | ||
Maximum [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available for sale debt securities, contractual maturities | '1 year | ' | ||
Recurring [Member] | Amortized Cost Basis [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 1,800 | [1] | 23,281 | [1] |
Recurring [Member] | Amortized Cost Basis [Member] | Fixed Income Securities [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 10,235 | [1],[2] | |
Recurring [Member] | Amortized Cost Basis [Member] | U.S. Government Agency debt securities [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 7,508 | [1],[2] | |
Recurring [Member] | Amortized Cost Basis [Member] | Former-auction corporate debt security [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 1,800 | [1],[3] | 1,740 | [1],[3] |
Recurring [Member] | Amortized Cost Basis [Member] | Preferred Equity [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 0 | [1] | 2,404 | [1] |
Recurring [Member] | Amortized Cost Basis [Member] | State and Municipal Debt [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 1,394 | [1],[3] | |
Recurring [Member] | Fair Value [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 3,447 | 26,561 | ||
Recurring [Member] | Fair Value [Member] | Fixed Income Securities [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 10,240 | [2] | |
Recurring [Member] | Fair Value [Member] | U.S. Government Agency debt securities [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 7,510 | [2] | |
Recurring [Member] | Fair Value [Member] | Former-auction corporate debt security [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 2,997 | [3] | 3,078 | [3] |
Recurring [Member] | Fair Value [Member] | Preferred Equity [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 450 | 4,081 | ||
Recurring [Member] | Fair Value [Member] | State and Municipal Debt [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 1,652 | [3] | |
Recurring [Member] | Quoted Prices in Active Markets for Identical Assets, Level 1 [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 0 | 7,510 | ||
Recurring [Member] | Quoted Prices in Active Markets for Identical Assets, Level 1 [Member] | Fixed Income Securities [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 0 | [2] | |
Recurring [Member] | Quoted Prices in Active Markets for Identical Assets, Level 1 [Member] | U.S. Government Agency debt securities [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 7,510 | [2] | |
Recurring [Member] | Quoted Prices in Active Markets for Identical Assets, Level 1 [Member] | Former-auction corporate debt security [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 0 | [3] | 0 | [3] |
Recurring [Member] | Quoted Prices in Active Markets for Identical Assets, Level 1 [Member] | Preferred Equity [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 0 | 0 | ||
Recurring [Member] | Quoted Prices in Active Markets for Identical Assets, Level 1 [Member] | State and Municipal Debt [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 0 | [3] | |
Recurring [Member] | Significant Other Observable Inputs, Level 2 [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 2,997 | 17,483 | ||
Recurring [Member] | Significant Other Observable Inputs, Level 2 [Member] | Fixed Income Securities [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 10,240 | [2] | |
Recurring [Member] | Significant Other Observable Inputs, Level 2 [Member] | U.S. Government Agency debt securities [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 0 | [2] | |
Recurring [Member] | Significant Other Observable Inputs, Level 2 [Member] | Former-auction corporate debt security [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 2,997 | [3] | 3,078 | [3] |
Recurring [Member] | Significant Other Observable Inputs, Level 2 [Member] | Preferred Equity [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 0 | 2,513 | ||
Recurring [Member] | Significant Other Observable Inputs, Level 2 [Member] | State and Municipal Debt [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 1,652 | [3] | |
Recurring [Member] | Significant Unobservable Inputs, Level 3 [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 450 | 1,568 | ||
Recurring [Member] | Significant Unobservable Inputs, Level 3 [Member] | Fixed Income Securities [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 0 | [2] | |
Recurring [Member] | Significant Unobservable Inputs, Level 3 [Member] | U.S. Government Agency debt securities [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | 0 | [2] | |
Recurring [Member] | Significant Unobservable Inputs, Level 3 [Member] | Former-auction corporate debt security [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 0 | [3] | 0 | [3] |
Recurring [Member] | Significant Unobservable Inputs, Level 3 [Member] | Preferred Equity [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | 450 | 1,568 | ||
Recurring [Member] | Significant Unobservable Inputs, Level 3 [Member] | State and Municipal Debt [Member] | ' | ' | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale securities | ' | $0 | [3] | |
[1] | Difference between amortized cost basis and fair value represents gross unrealized gain or loss. | |||
[2] | Available for sale debt securities with contractual maturities of one year or less. | |||
[3] | Available for sale debt securities with contractual maturities in excess of 10 years. |
FAIR_VALUE_AND_MARKETABLE_SECU3
FAIR VALUE AND MARKETABLE SECURITIES, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details) (USD $) | 12 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | ||||
DeafultInsurer | Significant Other Observable Inputs, Level 2 [Member] | Significant Unobservable Inputs, Level 3 [Member] | Significant Unobservable Inputs, Level 3 [Member] | Auction Rate Security - Preferred Equity [Member] | Auction Rate Security - Preferred Equity [Member] | Corporate Debt Security [Member] | Corporate Debt Security [Member] | Corporate Debt Security [Member] | Corporate Debt Security [Member] | Preferred Equity Securities Monoline insurers [Member] | Preferred Equity Securities Monoline insurers [Member] | |||||
Agency | Security | Security | Significant Other Observable Inputs, Level 2 [Member] | Significant Unobservable Inputs, Level 3 [Member] | Significant Unobservable Inputs, Level 3 [Member] | Significant Unobservable Inputs, Level 3 [Member] | Significant Unobservable Inputs, Level 3 [Member] | |||||||||
Subsequent Event [Member] | ||||||||||||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Balance, beginning of period | ' | ' | $1,568 | $1,843 | ' | ' | ' | ' | $0 | [1] | $1,215 | [1] | $1,568 | [2] | $628 | [2] |
Transfers into/out of Level 3 | ' | ' | 0 | 0 | ' | ' | ' | ' | 0 | [1] | 0 | [1] | 0 | [2] | 0 | [2] |
Total gains or losses realized/unrealized [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Included in net income | ' | ' | 872 | 1,250 | ' | ' | ' | ' | 0 | [1] | 1,250 | [1] | 872 | [2] | 0 | [2] |
Included in other comprehensive income(loss) | ' | ' | 10 | 488 | ' | ' | ' | ' | 0 | [1] | -452 | [1] | 10 | [2] | 940 | [2] |
Redemptions | ' | ' | -2,000 | -2,013 | ' | ' | ' | ' | 0 | [1] | -2,013 | [1] | -2,000 | [2] | 0 | [2] |
Balance, end of period | ' | ' | 450 | 1,568 | ' | ' | ' | ' | 0 | [1] | 0 | [1] | 450 | [2] | 1,568 | [2] |
Auction rate securities redeemed | ' | 2 | 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Number of credit rating agencies that approved investments | 2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Number of publicly held debt of default insurers | 2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Securities sold at par | ' | ' | ' | ' | 6,739 | 2,960 | ' | ' | ' | ' | ' | ' | ||||
Gain on sale | ' | ' | ' | ' | 1,684 | 1,160 | 1,250 | ' | ' | ' | ' | ' | ||||
Amount of total gains or losses for the period included in earnings(loss) attributable to the change in unrealized gains or losses relating to assets still held at the reporting date | ' | ' | 0 | ' | ' | ' | ' | ' | 0 | [1] | ' | 0 | [2] | ' | ||
Securities held: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Face value | ' | ' | $1,125 | ' | ' | ' | ' | $2,500 | $0 | [1] | ' | $1,125 | [2] | ' | ||
Financial ratings | ' | ' | ' | ' | ' | ' | ' | ' | '0 | [1] | ' | ' | ' | |||
Weighted average interest rate (in hundredths) | ' | ' | 0.00% | ' | ' | ' | ' | ' | 0.00% | [1] | ' | 0.00% | [2] | ' | ||
[1] | Security issued by a publicly-held insurance company trust, which holds investments in U.S. Government obligations, highly rated commercial paper and money market funds and other investments approved by two credit rating agencies. The $2,500 face value security was redeemed by the issuer at a discount in the first quarter of 2012 for $2,013, resulting in a gain over its amortized cost basis of $1,250. | |||||||||||||||
[2] | Preferred securities issued by subsidiaries of two publicly-held debt default insurers. During the second quarter of 2013, one of these securities redeemed at $2,000 par, resulting in an $872 realized gain recorded to Other income, net. |
INVENTORIES_Details
INVENTORIES (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Inventories [Abstract] | ' | ' |
Raw materials | $7,323 | $5,108 |
Work in progress | 8,424 | 9,781 |
Finished goods | 5,367 | 3,951 |
Total | $21,114 | $18,840 |
ACCRUED_LIABILITIES_Details
ACCRUED LIABILITIES (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Accrued Liabilities [Abstract] | ' | ' | ' |
Accrued compensation | $1,844 | $1,945 | ' |
Warranty reserve | 383 | 770 | ' |
Other | 2,153 | 1,630 | ' |
Total Accrued Liabilities | 4,380 | 4,345 | ' |
Product warranty reserve [Roll Forward] | ' | ' | ' |
Beginning balance | 770 | 430 | 571 |
Additions charged to costs and expenses | 554 | 1,507 | 871 |
Claims processed | -941 | -1,167 | -1,012 |
Ending balance | $383 | $770 | $430 |
COMMITMENTS_AND_CONTIGENCIES_D
COMMITMENTS AND CONTIGENCIES (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
COMMITMENTS AND CONTINGENCIES [Abstract] | ' | ' | ' |
Rent expense | $2,350 | $2,567 | $2,617 |
Capital lease obligations | 0 | 0 | ' |
Future Minimum Payments Operating Lease [Abstract] | ' | ' | ' |
2014 | 2,783 | ' | ' |
2015 | 2,630 | ' | ' |
2016 | 2,408 | ' | ' |
2017 | 210 | ' | ' |
2018 | 131 | ' | ' |
Thereafter | 11 | ' | ' |
Total minimum lease payments | 8,173 | ' | ' |
Unconditional Purchase Obligation | $2,073 | ' | ' |
INCOME_TAXES_Details
INCOME TAXES (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
INCOME TAXES [Abstract] | ' | ' | ' |
Current Federal Tax Benefit | $0 | $0 | $0 |
Deferred tax balances [Abstract] | ' | ' | ' |
Accruals/reserves | 7,652 | 9,091 | ' |
Net operating loss carryforwards | 210,894 | 181,815 | ' |
Research and experimentation credits | 14,414 | 14,086 | ' |
Deferred rent expense | 614 | 772 | ' |
Difference in basis of plant and equipment | 9,791 | 9,483 | ' |
Valuation allowance | -243,365 | -215,247 | ' |
Net deferred tax assets | 0 | 0 | ' |
Deferred tax asset associated with stock options and restricted stock | 25,149 | ' | ' |
Excess tax benefits, not recorded as deferred tax asset | 16,005 | ' | ' |
Reconciliation of income tax expense [Abstract] | ' | ' | ' |
Tax at U.S. statutory rate | -18,893 | -24,448 | -17,263 |
Effect of permanent items | 6 | 163 | -2 |
State and foreign tax (benefit), net of federal tax effect | -1,754 | -2,255 | -1,603 |
Research and experimentation tax credits, net | -328 | -33 | -68 |
Valuation allowance, net | 28,118 | 23,802 | 16,181 |
Worthless stock deduction | -4,997 | 0 | 0 |
Other | -2,152 | 2,771 | 2,755 |
(Benefit from) provision for income taxes | 0 | 0 | 0 |
Income tax rate reconciliation [Abstract] | ' | ' | ' |
Tax at U.S. statutory rate (in hundredths) | -35.00% | -35.00% | -35.00% |
Effect of permanent items (in hundredths) | 0.00% | 0.20% | 0.00% |
State and foreign tax (benefit), net of federal tax effect (in hundredths) | -3.20% | -3.20% | -3.30% |
Research and experimentation tax credits, net (in hundredths) | -0.60% | -0.10% | -0.10% |
Valuation allowance, net (in hundredths) | 52.10% | 34.10% | 32.80% |
Worthless stock deduction (in hundredths) | -9.30% | 0.00% | 0.00% |
Other (in hundredths) | -4.00% | 4.00% | 5.60% |
(Benefit from) provision for income taxes (in hundredths) | 0.00% | 0.00% | 0.00% |
Federal [Member] | ' | ' | ' |
Operating Loss Carryforwards [Line Items] | ' | ' | ' |
Net operating loss carryforwards | 578,346 | ' | ' |
State [Member] | ' | ' | ' |
Operating Loss Carryforwards [Line Items] | ' | ' | ' |
Net operating loss carryforwards | $290,117 | ' | ' |
STOCKHOLDERS_EQUITY_Details
STOCKHOLDERS' EQUITY (Details) (USD $) | 12 Months Ended | |
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Right | ||
STOCKHOLDERS' EQUITY [Abstract] | ' | ' |
Shares issued under public offering (in shares) | 10,704 | ' |
Share price (in dollars per share) | $2 | ' |
Net proceeds from shares purchased by underwriters | $19,675 | ' |
Number of rights distributed as dividend per share | 1 | ' |
Common stock, par value (in dollars per share) | $0.01 | $0.01 |
Right entitlement | 'one one-thousandth | ' |
Exercise price (in dollars per share) | $75 | ' |
Common stock beneficial ownership (in hundredths) | 18.00% | ' |
EMPLOYEE_BENEFIT_PLANS_Details
EMPLOYEE BENEFIT PLANS (Details) (USD $) | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Jun. 29, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Jun. 29, 2013 | Dec. 31, 2013 | Sep. 28, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Sep. 28, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |||||||||
Plan | $1.23 - $1.93 [Member] | $2.00 - $3.24 [Member] | $3.30 - $8.79 [Member] | $8.84 - $18.98 [Member] | Cost of Sales [Member] | Cost of Sales [Member] | Cost of Sales [Member] | Research and Development Expenses [Member] | Research and Development Expenses [Member] | Research and Development Expenses [Member] | Selling and administrative expenses [Member] | Selling and administrative expenses [Member] | Selling and administrative expenses [Member] | Restructuring charges [Member] | Restructuring charges [Member] | Restructuring charges [Member] | Stock options [Member] | Stock options [Member] | Stock options [Member] | Stock options [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock Units (RSUs) [Member] | Restricted Stock Units (RSUs) [Member] | Restricted Stock Units (RSUs) [Member] | Performance Award Shares [Member] | Performance Award Shares [Member] | Performance Award Shares [Member] | Performance Award Shares [Member] | Performance Award Shares [Member] | Performance Award Shares [Member] | Performance Award Shares [Member] | Time based Restricted Stock Units [Member] | Long Term Incentive and Share Award Plan 1995 [Member] | Long Term Incentive and Share Award Plan 1997 [Member] | Long Term Incentive and Share Award Plan 2005 [Member] | Long Term Incentive and Share Award Plan 2005 [Member] | Long Term Incentive and Share Award Plan 2005 [Member] | Long Term Incentive and Share Award Plan 2005 [Member] | Long Term Incentive and Share Award Plan 2005 [Member] | Employee Stock Purchase Plan [Member] | Employee Stock Purchase Plan [Member] | Employee Stock Purchase Plan [Member] | ||||||||||||
Maximum [Member] | Maximum [Member] | Minimum [Member] | Maximum [Member] | Maximum [Member] | Restricted Stock Units (RSUs) [Member] | Restricted Stock Units (RSUs) [Member] | Performance Award Shares [Member] | Time based Restricted Stock Units [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||
Recipient | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMPLOYEE BENEFIT PLANS [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Number of Equity Compensation Plans | 2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Number of equity compensation plans terminated | 2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Common stock reserved for issuance (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4,913 | 5,100 | 24,850 | ' | ' | ' | ' | 6,694 | ' | ' | |||||||||
Terms of award | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '10 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '10 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Awards vesting period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '3 years | ' | ' | ' | '3 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Shares purchased under ESP plan (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 271 | 407 | 384 | |||||||||
Purchase price of shares Under ESP Plan (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.64 | $2.04 | $2 | |||||||||
Share-based Compensation [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Stock based compensation | $6,516 | $5,797 | $11,514 | ' | ' | ' | ' | $1,041 | $888 | $1,798 | $2,118 | $1,626 | $2,981 | $3,428 | $3,218 | $6,815 | ($71) | $65 | ($80) | $128 | $670 | $1,899 | ' | $6,239 | $4,813 | $9,308 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $149 | $314 | $307 | |||||||||
Estimated annual forfeiture rate (in hundredths) | 2.50% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Restricted Stock Shares and Restricted Stock Units, Number of Shares [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Shares outstanding, Beginning balance (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 180 | ' | 1,430 | 1,970 | 1,460 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Granted (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | [1] | 0 | 0 | [1] | ' | 3,509 | [1] | 661 | 2,573 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 20 | 660 | 220 | 661 | ' | ' | ' | |||||
Shares vested/options exercised (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | -179 | ' | -1,539 | -1,102 | -1,654 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Forfeited/expired (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | [2],[3] | 0 | [2] | -1 | [2] | ' | -528 | [2],[3] | -99 | [2] | -409 | [2] | ' | ' | ' | ' | ' | ' | ' | -125 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Shares outstanding, Ending balance (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' | 2,872 | 1,430 | 1,970 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Restricted Stock Shares and Restricted Stock Units, Weighted Average Price [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average grant date fair value, Beginning balance (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | $0 | $8.39 | ' | $4.63 | $5.52 | $4.49 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Granted (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | [1] | $0 | $0 | [1] | ' | $2.11 | [1] | $2.32 | $5.91 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.55 | $0.77 | $0.80 | |||||
Shares vested/options exercised (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | $0 | $8.38 | ' | $3.34 | $4.69 | $5.08 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Forfeited/expired (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | [2],[3] | $0 | [2] | $9.72 | [2] | ' | $2.50 | [2],[3] | $6.21 | [2] | $6.03 | [2] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Weighted average grant date fair value, Ending balance (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | $0 | $0 | ' | $2.63 | $4.63 | $5.52 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Options outstanding [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Shares outstanding, Beginning balance (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,495 | 4,275 | 4,143 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Granted (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 13 | [1] | 13 | 1,065 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | 560 | ' | 417 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||
Options exercised (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -69 | -950 | -442 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Forfeited/expired (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -480 | [2],[3] | -843 | [2] | -491 | [2] | ' | ' | ' | ' | ' | ' | ' | ' | -83 | -42 | -83 | -167 | ' | -125 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||
Shares outstanding, Ending balance (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,959 | 2,495 | 4,275 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Options, Weighted Average Exercise Price [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average exercise price per share, Beginning balance (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $4.89 | $4.32 | $4.96 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average exercise price, Granted (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2.26 | [1] | $1.97 | $3.29 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||
Weighted average exercise price, Shares vested/options exercised (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.93 | $2.02 | $2.12 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average exercise price, Forfeited/expired (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $3.99 | [2],[3] | $5.21 | [2] | $9.37 | [2] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||
Weighted average exercise price per share, Ending balance (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $5.20 | $4.89 | $4.32 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Exercisable options (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,840 | 2,011 | 3,485 | ' | ' | ' | ' | ' | ' | ' | ' | ' | 384 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Average exercise prices (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $5.33 | $5.27 | $4.55 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Award vesting rights | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 'The time-based restricted stock units vested one-third on May 20, 2013, and vest one-third on February 18, 2014 and one-third on February 18, 2015. The performance-based restricted stock units vest based on absolute total stockholder return for one-year, two-year and three-year periods starting from the baseline date of December 31, 2011, compared to total stockholder return targets for each of the respective periods. | 'The award and performance will be evaluated annually in one-third increments measuring Company shareholder returns during the one, two and three year periods following the award. Depending upon performance, the number of shares issuable pursuant to the performance-based stock options can range from 50% to 150% of the base option shares. Company performance below the 25th-percentile in a measurement period would result in no vesting for that period. | ' | ' | ' | ' | |||||||||
Average fair value (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.36 | $1.14 | $1.85 | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2.62 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Percentage of shares issuable pursuant to long term incentive stock options (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | ' | 150.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Number of award recipients | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2 | ' | ' | ' | ' | ' | |||||||||
Percentage of restricted stock units will have time based vesting conditions (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | ' | ' | ' | ' | ' | |||||||||
Percentage of restricted stock units will have performance based vesting conditions (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | ' | ' | ' | ' | ' | |||||||||
Fair value of restricted stock vested | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,052 | 2,208 | 6,942 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Intrinsic value of exercised options | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 14 | 512 | 787 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Units issuable depending upon performance (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 111 | ' | ' | ' | ' | ' | ' | ' | |||||||||
Percentage of units issuable depending upon performance (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 34.80% | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted Average Information [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Options currently exercisable, shares issuable upon exercise (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,840 | 2,011 | 3,485 | ' | ' | ' | ' | ' | ' | ' | ' | ' | 384 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average exercise price (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $5.33 | $5.27 | $4.55 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average remaining contractual term | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '3 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average remaining contractual term for outstanding options | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '3 years 3 months 18 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Intrinsic value of exercisable options | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Intrinsic value of outstanding options | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Unrecognized stock-based compensation cost [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Option plans and restricted stock | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 109 | ' | ' | ' | 3,304 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average remaining contractual term for outstanding options and restricted stock | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '0 years 8 months 12 days | ' | ' | ' | '1 year 3 months 18 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average assumptions and fair values for stock-based compensation grants [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Risk-free interest rate (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0.80% | 1.00% | 2.20% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0.10% | 0.20% | 0.10% | |||||||||
Expected volatility (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 72.00% | 70.00% | 65.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 51.00% | 61.00% | 66.00% | |||||||||
Average expected term (in years) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | '5 years | '5 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '1 year | '1 year | '1 year | |||||||||
Expected dividend yield (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0.00% | 0.00% | 0.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0.00% | 0.00% | 0.00% | |||||||||
Weighted average fair value of options granted (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.36 | $1.14 | $1.85 | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2.62 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average fair value of purchase option (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | [1] | $0 | $0 | [1] | ' | $2.11 | [1] | $2.32 | $5.91 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.55 | $0.77 | $0.80 | |||||
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Exercise price range, lower range limit (in dollars per share) | ' | ' | ' | $1.23 | $2 | $3.30 | $8.84 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Exercise price range, upper range limit (in dollars per share) | ' | ' | ' | $1.93 | $3.24 | $8.79 | $18.98 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Outstanding options (in shares) | ' | ' | ' | 646 | 322 | 493 | 498 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average remaining contractual life | ' | ' | ' | '3 years 8 months 12 days | '7 years 3 months 18 days | '1 year | '2 years 4 months 24 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average exercise price (in dollars per share) | ' | ' | ' | $1.93 | $3.18 | $6.56 | $9.40 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Exercisable options (in shares) | ' | ' | ' | 641 | 209 | 492 | 498 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Weighted average exercise price (in dollars per share) | ' | ' | ' | $1.93 | $3.19 | $6.56 | $9.40 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Defined contribution pension [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Employer matching contribution (in hundredths) | 30.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Maximum annual contribution per employee (in hundredths) | 10.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
Recorded expense | $829 | $855 | $928 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||
[1] | Year 2011 stock options granted include 417 performance-based stock option shares; Year 2013 restricted stock units granted include 560 performance-based restricted stock units. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[2] | Years 2011, 2012, and 2013 stock options forfeited include 167, 83 and 42 performance-based option shares, respectively; Year 2013 restricted stock units forfeited include 384 performance-based units. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[3] | In the second quarter of 2013, 125 time-based and 83 (125 at maximum performance achievement) performance-based stock options were rescinded with the consent of and without payment to the CEO due to the fact that the original grants with respect to which these options were a part of exceeded the sub-limits of the applicable plan by the number of shares as to which the options were rescinded. |
LOSS_PER_SHARE_Details
LOSS PER SHARE (Details) | 12 Months Ended | |||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |||
LOSS PER SHARE [Abstract] | ' | ' | ' | |||
Weighted average common shares for basic loss per share (in shares) | 80,991 | 70,721 | 67,771 | |||
Effect of dilutive securities: | ' | ' | ' | |||
Stock options (in shares) | 0 | [1] | 0 | [1] | 0 | [1] |
Unvested restricted stock (in shares) | 0 | [1] | 0 | [1] | 0 | [1] |
Adjusted weighted average shares for diluted loss per share (in shares) | 80,991 | 70,721 | 67,771 | |||
Stock options [Member] | ' | ' | ' | |||
Antidilutive Securities Excluded From Computation Of Earning Per Share [Abstract] | ' | ' | ' | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 1,959 | 2,495 | 4,275 | |||
Unvested restricted stock [Member] | ' | ' | ' | |||
Antidilutive Securities Excluded From Computation Of Earning Per Share [Abstract] | ' | ' | ' | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 2,872 | 1,430 | 1,970 | |||
[1] | Incremental shares from restricted stock and stock options are computed using the treasury stock method. |
OTHER_ACCUMULATED_COMPREHENSIV2
OTHER ACCUMULATED COMPREHENSIVE INCOME (Details) (USD $) | 12 Months Ended | ||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | ||
Accumulated Other Comprehensive Income Loss [Line Items] | ' | ' | ' | ||
Beginning Balance | $2,052 | $1,246 | ' | ||
Other comprehensive income before reclassifications | 1,374 | 2,199 | ' | ||
Amounts reclassified from accumulated other comprehensive income | -1,779 | [1] | -1,393 | [1] | ' |
Net current period other comprehensive income | -405 | 806 | -336 | ||
Ending Balance | 1,647 | 2,052 | 1,246 | ||
Net Unrealized Gain (Loss) on Marketable Securities [Member] | ' | ' | ' | ||
Accumulated Other Comprehensive Income Loss [Line Items] | ' | ' | ' | ||
Beginning Balance | 2,055 | 1,255 | ' | ||
Other comprehensive income before reclassifications | 1,371 | 2,193 | ' | ||
Amounts reclassified from accumulated other comprehensive income | -1,779 | [1] | -1,393 | [1] | ' |
Net current period other comprehensive income | -408 | 800 | ' | ||
Ending Balance | 1,647 | 2,055 | ' | ||
Foreign Currency Translation [Member] | ' | ' | ' | ||
Accumulated Other Comprehensive Income Loss [Line Items] | ' | ' | ' | ||
Beginning Balance | -3 | -9 | ' | ||
Other comprehensive income before reclassifications | 3 | 6 | ' | ||
Amounts reclassified from accumulated other comprehensive income | 0 | [1] | 0 | [1] | ' |
Net current period other comprehensive income | 3 | 6 | ' | ||
Ending Balance | $0 | ($3) | ' | ||
[1] | Amounts reclassified are recorded within Other income, net in the Consolidated Statements of Operations |
LINE_OF_CREDIT_Details
LINE OF CREDIT (Details) (Line Of Credit [Member], USD $) | 1 Months Ended |
In Thousands, unless otherwise specified | Apr. 30, 2013 |
Line Of Credit [Member] | ' |
Line Of Credit Facility [Line Items] | ' |
Term of line of credit facility | '3 years |
Revolving credit facility, Amount | $11,000 |
Revolving credit facility, Expiration date | 30-Apr-16 |
Variable rate basis | 'LIBOR |
Basis spread on variable rate (in hundredths) | 3.25% |
QUARTERLY_FINANCIAL_DATA_UNAUD2
QUARTERLY FINANCIAL DATA (UNAUDITED) (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Sep. 28, 2013 | Jun. 29, 2013 | Mar. 30, 2013 | Dec. 31, 2012 | Sep. 29, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
QUARTERLY FINANCIAL DATA (UNAUDITED) [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | $36,286 | $37,011 | $34,565 | $26,380 | $30,476 | $28,642 | $25,099 | $28,426 | $134,242 | $112,643 | $152,827 |
Cost of sales | 31,640 | 32,912 | 34,269 | 27,101 | 31,017 | 28,809 | 27,296 | 26,747 | 125,922 | 113,869 | 121,724 |
Gross profit (loss) | 4,646 | 4,099 | 296 | -721 | -541 | -167 | -2,197 | 1,679 | 8,320 | -1,226 | 31,103 |
Research and development expenses | 9,321 | 9,551 | 9,433 | 10,280 | 10,145 | 10,823 | 11,310 | 11,614 | 38,585 | 43,892 | 45,037 |
Selling and administrative expense | 5,574 | 5,782 | 6,215 | 6,242 | 5,516 | 5,597 | 6,321 | 6,855 | 23,813 | 24,289 | 35,138 |
Restructuring charges | 0 | 0 | 0 | 1,915 | 0 | 605 | 1,239 | 494 | 1,915 | 2,338 | 1,047 |
Operating loss | -10,249 | -11,234 | -15,352 | -19,158 | -16,202 | -17,192 | -21,067 | -17,284 | -55,993 | -71,745 | -50,119 |
Interest income | 33 | 46 | 65 | 93 | 117 | 128 | 133 | 150 | 237 | 528 | 576 |
Interest expense | -31 | -31 | -20 | 0 | 0 | 0 | 0 | 0 | -82 | 0 | -25 |
Other income, net | 290 | 15 | 1,508 | 46 | 24 | 25 | 1 | 1,314 | 1,859 | 1,364 | 245 |
Net loss | ($9,957) | ($11,204) | ($13,799) | ($19,019) | ($16,061) | ($17,039) | ($20,933) | ($15,820) | ($53,979) | ($69,853) | ($49,323) |
Net loss per share: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Basic (in dollars per share) | ($0.12) | ($0.13) | ($0.17) | ($0.26) | ($0.23) | ($0.24) | ($0.30) | ($0.23) | ' | ' | ' |
Diluted (in dollars per share) | ($0.12) | ($0.13) | ($0.17) | ($0.26) | ($0.23) | ($0.24) | ($0.30) | ($0.23) | ($0.67) | ($0.99) | ($0.73) |
SCHEDULE_IIVALUATION_AND_QUALI1
SCHEDULE II--VALUATION AND QUALIFYING ACCOUNTS (Details) (USD $) | 12 Months Ended | |||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |||
Allowance for doubtful accounts [Member] | ' | ' | ' | |||
Valuation and Qualifying Accounts Disclosure [Line Items] | ' | ' | ' | |||
Balance at beginning of period | $172 | $172 | $739 | |||
Additions charged to costs and expenses | 0 | 0 | 0 | |||
Deductions | 0 | [1] | 0 | [1] | -567 | [1] |
Balance at end of period | 172 | 172 | 172 | |||
Reserve for excess and obsolete inventory [Member] | ' | ' | ' | |||
Valuation and Qualifying Accounts Disclosure [Line Items] | ' | ' | ' | |||
Balance at beginning of period | 5,887 | 5,559 | 8,948 | |||
Additions charged to costs and expenses | 122 | 1,317 | 137 | |||
Deductions | -2,031 | [2] | -989 | [2] | -3,526 | [2] |
Balance at end of period | $3,978 | $5,887 | $5,559 | |||
[1] | Uncollectible accounts written-off to the allowance account. | |||||
[2] | Inventory write-offs to the reserve account. |